<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01168401</url>
  </required_header>
  <id_info>
    <org_study_id>LV03-104</org_study_id>
    <secondary_id>U1111-1187-1052</secondary_id>
    <nct_id>NCT01168401</nct_id>
  </id_info>
  <brief_title>Bivalent Norovirus Vaccine Study</brief_title>
  <official_title>Phase 1, Randomized Controlled Dose Escalation, Safety and Immunogenicity Study of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine Adjuvanted With Monophosphoryl Lipid A (MPL) and Aluminum Hydroxide [Al(OH)3] in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, multi-site, dose-escalation study of the safety and immunogenicity of four dosage
      levels of Intramuscular (IM) Norovirus Bivalent VLP Vaccine adjuvanted with MPL and Al(OH)3
      compared to controls. Participants will receive two doses, by IM injection, 28 days apart.

      The hypotheses for this study are:

        -  The incidence of adverse events after vaccination with IM Norovirus Bivalent VLP Vaccine
           will be similar to the incidence of adverse events after other IM vaccines including
           CERVARIXÂ® which contains MPL and Al(OH)3.

        -  Two doses of IM Norovirus Bivalent VLP Vaccine will be more immunogenic than one dose.

        -  The post-vaccination serum antibody responses, the number of antibody secreting cells
           (ASC), including homing markers, and memory B-cell responses directed against norovirus
           antigens will be increased after IM Norovirus Bivalent VLP Vaccine compared to controls.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2010</start_date>
  <completion_date type="Actual">January 9, 2013</completion_date>
  <primary_completion_date type="Actual">January 1, 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Solicited Local Adverse Events (AEs) Post Dose 1</measure>
    <time_frame>Day 0 up to Day 7</time_frame>
    <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfere with activity); Moderate (repeated use of non-narcotic pain reliever greater than (&gt;) 24 hours [24h] or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 centimeter [cm] and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Local AEs Post Dose 2</measure>
    <time_frame>Day 28 up to Day 35</time_frame>
    <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfered with activity); Moderate (repeated use of non-narcotic pain reliever &gt;24h or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 cm and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Systemic AEs Post Dose 1</measure>
    <time_frame>Day 0 up to Day 7</time_frame>
    <description>Elevated oral temperature:Mild(38-38.4 Celsius[C]);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400gram[g]/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required intravenous[IV]hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Systemic AEs Post Dose 2</measure>
    <time_frame>Day 28 up to Day 35</time_frame>
    <description>Elevated oral temperature:Mild(38-38.4 C);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400g/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required IV hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Unsolicited AEs Post Dose 1</measure>
    <time_frame>Baseline up to Day 28 (Pre-dose 2)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Unsolicited AEs Post Dose 2</measure>
    <time_frame>Day 28 up to Day 56 (Post dose 2)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Change From Baseline in Markedly Abnormal Laboratory Values</measure>
    <time_frame>Baseline up to Day 35</time_frame>
    <description>The number of participants with any markedly abnormal standard safety laboratory values (serum chemistry or hematology) collected throughout study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Serious Adverse Events (SAEs), Onset of Significant New Medical Conditions, Including Adverse Events of Special Interest (AESI)</measure>
    <time_frame>Baseline up to 365 Days after post dose 2 (Day 393)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) of Serum Anti-norovirus GI.1 and GII.4 VLP Ig (Immunoglobulin) A</measure>
    <time_frame>First (I) run: predose 1 and 7, 21, 28 days postdose (PD)1, and 7 and 28 days PD2; second (II) run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgG</measure>
    <time_frame>I run: predose 1 and 7, 21, 28 days PD1, and 7 and 28 days PD2; II run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgM</measure>
    <time_frame>I run: predose 1 and 7, 21, 28 days PD1, and 7 and 28 days PD2; II run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Rise (GMFR) of Serum Anti-norovirus GI.1 and GII.4 VLP IgA as Compared to Baseline</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgG as Compared to Baseline</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgM as Compared to Baseline</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgA</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgG</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgM</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMT of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig Enzyme-Linked Immunosorbent Assay (ELISA)</measure>
    <time_frame>I run: predose 1, 7, 21, 28 days PD1, 7 and 28 days PD2; II run: predose 1, 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>GMTs were assessed for Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMFR of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA as Compared to Baseline</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>GMFRs in GMTs of Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Seroresponse (4-Fold Rise) of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA</measure>
    <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
    <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Gastroenteritis</condition>
  <arm_group>
    <arm_group_label>NoV GI.1/GII.4 Bivalent VLP Vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Norovirus Bivalent GI.1 and GII.4 VLP Vaccine, adjuvanted with 50 microgram (mcg) MPL and 500 mcg Al(OH)3, IM, on Days 0 and 28.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>NoV GI.1/GII.4 Bivalent VLP Vaccine</intervention_name>
    <description>2 Doses 28 days apart Cohort A: 18-49 Years
Cohort A1: IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (5/5 mcg)
Cohort A2: IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (15/15 mcg)
Cohort A3: IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (50/50 mcg)
Cohort A4: IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (150/150 mcg)
Cohort B: 50-64 Years IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (50/50 mcg)
Cohort C: 65-85 Years IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (50/50 mcg)
Cohort D: 18-49 Years IM Norovirus Bivalent GI.1/GII.4 VLP Vaccine (50/50 mcg)</description>
    <arm_group_label>NoV GI.1/GII.4 Bivalent VLP Vaccine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Two doses 28 days apart</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants must meet all of the inclusion criteria listed below:

          1. Signed written informed consent.

          2. Age:

               -  Cohort A: 18-49 years, inclusive

               -  Cohort B: 50-64 years, inclusive

               -  Cohort C: 65-85 years, inclusive

               -  Cohort D: 18-49 years, inclusive

          3. Health Status:

               -  Cohort A and D: In good health as determined by a screening evaluation that
                  includes vital signs, medical history, and physical exam within 45 days before
                  administration of IM Norovirus Bivalent VLP Vaccine or control.

               -  Cohorts B and C: In good health as determined by a screening evaluation that
                  includes vital signs, medical history, and physical exam within 45 days before
                  administration of IM Norovirus Bivalent VLP Vaccine or control. Any existing
                  medical diagnoses or conditions must be stable based on medical history and
                  targeted physical examination. A stable medical condition is defined as: (A)
                  Clinically acceptable health outcomes for the specific condition over the prior 6
                  months and (B) No change in prescription medication(s), dose, or frequency over
                  the prior 3 months. Acceptable changes in medications are: a change of health
                  care provider or insurance company or that is made for financial reasons as long
                  as the medications are in the same class and/or a change due to improvement in a
                  disease outcome.

          4. Expressed interest and availability to fulfill the study requirements.

          5. Female participants must be of non-childbearing potential (surgically sterile or
             post-menopausal for greater than or equal to [&gt;=] 12 months), or if of childbearing
             potential (as determined by the investigator) must be practicing abstinence or using
             an effective licensed method of birth control (example oral contraceptives; diaphragm
             or condom in combination with contraceptive jelly, cream, or foam; intrauterine
             contraceptive device, or Depo-Provera; skin patch; vaginal ring or cervical cap) for
             30 days prior to vaccination and must agree to continue such precautions for at least
             60 days after the last vaccination. A woman is eligible if she is monogamous with a
             male who has had a vasectomy. Male participants must agree not to father a child for
             at least 60 days after the last vaccination and to practice abstinence or use an
             effective method of birth control as noted above.

          6. Agrees not to participate in another clinical trial with an investigational product
             for the entire duration of the study one year after the last study dose that is 393
             days.

          7. Agrees to storage of unused clinical specimens for an indefinite period of time for
             future norovirus research or research on other gastrointestinal pathogens.

        Exclusion Criteria:

        Participants who meet any of the exclusion criteria at baseline will be excluded from study
        participation. The exclusion criteria are:

          1. History of any of the following medical illnesses:

               -  Diabetes

               -  Cancer (malignancy other than resolved/excised skin lesion)

               -  Heart disease (hospitalization for a heart attack, arrhythmia, or syncope)

               -  Unconsciousness (other than a single brief &quot;concussion&quot;)

               -  Seizures (other than febrile seizures as a child less than [&lt;] 5 years old)

               -  Recurrent infections (more than 3 hospitalizations for invasive bacterial
                  infections such as pneumonia or meningitis)

               -  Any condition associated with immunodeficiency or participants taking
                  immunosuppressant medication

               -  Neuroinflamatory or auto-immune disease

          2. Any current illness requiring daily medication other than the following:

               -  Cohort A and D: Vitamins, birth control, anti-hypertensive medication,
                  antihistamines or anti-depressant medication. The Principal Investigator (PI)
                  should consult with the Central Safety Monitor and/or the sponsor for any
                  clarification of medications allowable.

               -  Cohorts B and C: Vitamins, birth control, anti-hypertensive medication,
                  antihistamines or anti-depressant medication or any current illness requiring
                  daily medication other than as noted above in inclusion criteria 3. The PI should
                  consult with the Central Safety Monitor and/or the sponsor for any clarification
                  of medications allowable.

          3. Allergies or hypersensitivity to any component of the vaccine including MPL and
             Al(OH)3 adjuvants.

          4. Any clinically significant abnormality detected on physical examination, including:

               -  Murmur (other than a functional murmur)

               -  Focal neurological abnormality

               -  Hepatosplenomegaly

               -  Lymphadenopathy

               -  Jaundice

          5. Hypertension (Blood Pressure [BP] greater than [&gt;] 140/90 millimeter of mercury [mm
             Hg] on two separate days)

          6. Any lab abnormality (per the site local laboratory), as listed below:

               -  Absolute Neutrophil Count (ANC) outside the normal range (may be repeated if
                  outside this limit)

               -  Total white blood cells (WBC) outside the normal range (may be repeated if
                  outside this limit)

               -  Hemoglobin outside the normal range (may be repeated if outside this limit)

               -  Platelet count outside the normal range (may be repeated if outside this limit)

               -  Blood urea nitrogen (BUN) &gt; upper limit of normal (ULN) (may be repeated if
                  outside this limit)

               -  Creatinine &gt; ULN (may be repeated if outside this limit)

               -  Glucose (fasting or random) outside the normal range (may be repeated if outside
                  this limit)

               -  Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) &gt; ULN (may be
                  repeated if outside this limit)

          7. Positive serology for hepatitis C or Human Immunodeficiency Virus (HIV) antibody or
             hepatitis B surface antigen.

          8. For women of child bearing potential, positive serum pregnancy test within 14 days and
             urine pregnancy test within 24 hours of administering either dose of IM Norovirus
             Bivalent VLP Vaccine or control.

          9. Nursing mother.

         10. Temperature &gt;100.4 degree Fahrenheit (F) or symptoms of an acute self-limited illness
             such as an upper respiratory infection or gastroenteritis within 3 days of
             administration of IM Norovirus Bivalent VLP Vaccine or control.

         11. Previous participation in a Norovirus vaccine or challenge study.

         12. Study site personnel or their family members.

         13. Significant history of psychiatric hospitalization, alcohol abuse, or illicit drug use
             in the prior 5 years.

         14. Completion of an investigational vaccine or drug study within 28 days before
             administration of IM Norovirus Bivalent VLP Vaccine or control.

         15. Have a history of receiving immunoglobulin or other blood product within the 3 months
             prior to vaccination in this study.

         16. Other condition that in the clinical judgment of the investigator would jeopardize the
             safety or rights of a participant participating in the trial, would render the
             participant unable to comply with the protocol or would interfere with the evaluation
             of the vaccine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Navy Medical Research Center</name>
      <address>
        <city>Silver Springs</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>July 21, 2010</study_first_submitted>
  <study_first_submitted_qc>July 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2010</study_first_posted>
  <results_first_submitted>May 4, 2017</results_first_submitted>
  <results_first_submitted_qc>April 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 23, 2018</results_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaccine, norovirus, acute gastroenteritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroenteritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at 3 investigative sites in the United States from 03 September 2010 to 09 January 2013.</recruitment_details>
      <pre_assignment_details>Healthy volunteers were enrolled in 1 of the following treatment groups: Bivalent Norovirus GI.1/GII.4 Vaccine (Cohort A: 5/5 microgram [mcg], 15/15 mcg, 50/50 mcg, 150/150 mcg; Cohort B: 50/50 mcg; Cohort C: 50/50 mcg and Cohort D: 50/50 mcg) adjuvanted with 50 mcg monophosphoryl lipid A (MPL) and 500 mcg aluminum hydroxide [Al(OH)3]) or Placebo.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
          <description>Norovirus bivalent Virus-Like Particle (VLP) Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P2">
          <title>Cohort A2:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P3">
          <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P4">
          <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
          <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P5">
          <title>Cohort A1-A4: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9 percent [%] sodium chloride [NaCl] and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P6">
          <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="P7">
          <title>Cohort B: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="P8">
          <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="P9">
          <title>Cohort C: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="P10">
          <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="P11">
          <title>Cohort D: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="9"/>
                <participants group_id="P6" count="9"/>
                <participants group_id="P7" count="10"/>
                <participants group_id="P8" count="10"/>
                <participants group_id="P9" count="9"/>
                <participants group_id="P10" count="8"/>
                <participants group_id="P11" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="7"/>
                <participants group_id="P5" count="9"/>
                <participants group_id="P6" count="9"/>
                <participants group_id="P7" count="10"/>
                <participants group_id="P8" count="10"/>
                <participants group_id="P9" count="9"/>
                <participants group_id="P10" count="8"/>
                <participants group_id="P11" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Modified Intent to Treat (mITT) population included all participants who received at least 1 dose of study product.</population>
      <group_list>
        <group group_id="B1">
          <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B2">
          <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B3">
          <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B4">
          <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
          <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B5">
          <title>Cohort A1-A4: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B6">
          <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="B7">
          <title>Cohort B: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="B8">
          <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="B9">
          <title>Cohort C: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="B10">
          <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B11">
          <title>Cohort D: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="B12">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="9"/>
            <count group_id="B5" value="9"/>
            <count group_id="B6" value="9"/>
            <count group_id="B7" value="10"/>
            <count group_id="B8" value="10"/>
            <count group_id="B9" value="9"/>
            <count group_id="B10" value="8"/>
            <count group_id="B11" value="8"/>
            <count group_id="B12" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Greater than or equal to (&gt;=) 18 and &lt;64 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="8"/>
                    <measurement group_id="B11" value="8"/>
                    <measurement group_id="B12" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="5"/>
                    <measurement group_id="B8" value="8"/>
                    <measurement group_id="B9" value="5"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="68"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="5"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="8"/>
                    <measurement group_id="B11" value="8"/>
                    <measurement group_id="B12" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="5"/>
                    <measurement group_id="B12" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="8"/>
                    <measurement group_id="B12" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Saliva Secretor Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Saliva Secretor Status Positive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="8"/>
                    <measurement group_id="B8" value="8"/>
                    <measurement group_id="B9" value="7"/>
                    <measurement group_id="B10" value="7"/>
                    <measurement group_id="B11" value="5"/>
                    <measurement group_id="B12" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Saliva Secretor Status Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Blood Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Blood Type A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="6"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Type B</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Type O</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="5"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Type AB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Local Adverse Events (AEs) Post Dose 1</title>
        <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfere with activity); Moderate (repeated use of non-narcotic pain reliever greater than (&gt;) 24 hours [24h] or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 centimeter [cm] and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
        <time_frame>Day 0 up to Day 7</time_frame>
        <population>mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Local Adverse Events (AEs) Post Dose 1</title>
          <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfere with activity); Moderate (repeated use of non-narcotic pain reliever greater than (&gt;) 24 hours [24h] or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 centimeter [cm] and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
          <population>mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Local AEs Post Dose 2</title>
        <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfered with activity); Moderate (repeated use of non-narcotic pain reliever &gt;24h or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 cm and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
        <time_frame>Day 28 up to Day 35</time_frame>
        <population>mITT population where Day 28 to 35 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Local AEs Post Dose 2</title>
          <description>The solicited local adverse events were reported using a memory aid. Pain was scaled as Mild (did not interfered with activity); Moderate (repeated use of non-narcotic pain reliever &gt;24h or interfered with activity); and Severe (any use of narcotic pain reliever or prevented daily activity). Tenderness was scaled as Mild (mild discomfort to touch); Moderate (discomfort with movement); and Severe (significant discomfort at rest). Swelling and redness were scaled as Mild (2.5-5 cm and did not interfere with activity); Moderate (5.1-10 cm or interfered with activity); and Severe (&gt;10 cm or prevented daily activity).</description>
          <population>mITT population where Day 28 to 35 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Systemic AEs Post Dose 1</title>
        <description>Elevated oral temperature:Mild(38-38.4 Celsius[C]);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400gram[g]/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required intravenous[IV]hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
        <time_frame>Day 0 up to Day 7</time_frame>
        <population>mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Systemic AEs Post Dose 1</title>
          <description>Elevated oral temperature:Mild(38-38.4 Celsius[C]);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400gram[g]/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required intravenous[IV]hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
          <population>mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Headache: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue/ Malaise: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue/ Malaise: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle Aches : Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle Aches : Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint Aches: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint Aches: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal Cramps/Discomfort: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal Cramps/Discomfort: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Systemic AEs Post Dose 2</title>
        <description>Elevated oral temperature:Mild(38-38.4 C);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400g/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required IV hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
        <time_frame>Day 28 up to Day 35</time_frame>
        <population>mITT population where Day 28 to 35 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Systemic AEs Post Dose 2</title>
          <description>Elevated oral temperature:Mild(38-38.4 C);Moderate(38.5-38.9 C);Severe(39-40 C).Headache:Mild(no interference with activity);Moderate(repeated use of non-narcotic pain reliever&gt;24h/some interference with activity);Severe(significant;any use of narcotic pain reliever/prevented daily activity).Fatigue,Malaise:Mild(no interference with activity);Moderate(some interference with activity);Severe(significant;prevented daily activity).Diarrhea:Mild(2-3loose stools/&lt;400g/24h);Moderate(4-5stools/400-800g/24h);Severe(&gt;=6watery stools/&gt;800g/24h/required IV hydration).Nausea/Vomiting:Mild(no interference with activity/1-2 episodes/24h);Moderate(some interference with activity/&gt;2 episodes/24h);Severe(prevented daily activity,required IV hydration).Muscle ache,chills,joint ache,abdominal cramp/pain:Mild(no interference with activity);Moderate(some interference with activity,not required medical intervention);Severe(prevented daily activity,required medical intervention).</description>
          <population>mITT population where Day 28 to 35 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product. Only those categories have been reported below where at least 1 participant experienced the event.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Headache: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue/ Malaise: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue/ Malaise: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle Aches: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle Aches: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint Aches: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint Aches: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal Cramps/Discomfort: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Unsolicited AEs Post Dose 1</title>
        <time_frame>Baseline up to Day 28 (Pre-dose 2)</time_frame>
        <population>mITT population included all participants who received at least 1 dose of study product.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Unsolicited AEs Post Dose 1</title>
          <population>mITT population included all participants who received at least 1 dose of study product.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Unsolicited AEs Post Dose 2</title>
        <time_frame>Day 28 up to Day 56 (Post dose 2)</time_frame>
        <population>mITT population where Day 28 to 56 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Unsolicited AEs Post Dose 2</title>
          <population>mITT population where Day 28 to 56 assessment were available for this measure. mITT population included all participants who received at least 1 dose of study product.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Significant Change From Baseline in Markedly Abnormal Laboratory Values</title>
        <description>The number of participants with any markedly abnormal standard safety laboratory values (serum chemistry or hematology) collected throughout study.</description>
        <time_frame>Baseline up to Day 35</time_frame>
        <population>mITT population included all participants who received at least 1 dose of study product.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Significant Change From Baseline in Markedly Abnormal Laboratory Values</title>
          <description>The number of participants with any markedly abnormal standard safety laboratory values (serum chemistry or hematology) collected throughout study.</description>
          <population>mITT population included all participants who received at least 1 dose of study product.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Serious Adverse Events (SAEs), Onset of Significant New Medical Conditions, Including Adverse Events of Special Interest (AESI)</title>
        <time_frame>Baseline up to 365 Days after post dose 2 (Day 393)</time_frame>
        <population>mITT population included all participants who received at least 1 dose of study product.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Serious Adverse Events (SAEs), Onset of Significant New Medical Conditions, Including Adverse Events of Special Interest (AESI)</title>
          <population>mITT population included all participants who received at least 1 dose of study product.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Medical Conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) of Serum Anti-norovirus GI.1 and GII.4 VLP Ig (Immunoglobulin) A</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>First (I) run: predose 1 and 7, 21, 28 days postdose (PD)1, and 7 and 28 days PD2; second (II) run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>Per Protocol (PP) population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) of Serum Anti-norovirus GI.1 and GII.4 VLP Ig (Immunoglobulin) A</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>Per Protocol (PP) population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="3" upper_limit="26"/>
                    <measurement group_id="O2" value="5" lower_limit="3" upper_limit="7"/>
                    <measurement group_id="O3" value="5" lower_limit="3" upper_limit="10"/>
                    <measurement group_id="O4" value="6" lower_limit="3" upper_limit="13"/>
                    <measurement group_id="O5" value="10" lower_limit="3" upper_limit="32"/>
                    <measurement group_id="O6" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="3" lower_limit="3" upper_limit="3"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="204" lower_limit="126" upper_limit="332"/>
                    <measurement group_id="O2" value="357" lower_limit="141" upper_limit="906"/>
                    <measurement group_id="O3" value="458" lower_limit="97" upper_limit="2154"/>
                    <measurement group_id="O4" value="675" lower_limit="136" upper_limit="3334"/>
                    <measurement group_id="O5" value="7" lower_limit="2" upper_limit="20"/>
                    <measurement group_id="O6" value="357" lower_limit="110" upper_limit="1158"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="208" lower_limit="48" upper_limit="903"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="40" lower_limit="13" upper_limit="120"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164" lower_limit="87" upper_limit="311"/>
                    <measurement group_id="O2" value="164" lower_limit="71" upper_limit="379"/>
                    <measurement group_id="O3" value="269" lower_limit="90" upper_limit="799"/>
                    <measurement group_id="O4" value="307" lower_limit="84" upper_limit="1115"/>
                    <measurement group_id="O5" value="9" lower_limit="3" upper_limit="26"/>
                    <measurement group_id="O6" value="252" lower_limit="151" upper_limit="421"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O8" value="114" lower_limit="31" upper_limit="423"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="31" lower_limit="10" upper_limit="96"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="143" lower_limit="70" upper_limit="293"/>
                    <measurement group_id="O2" value="106" lower_limit="42" upper_limit="267"/>
                    <measurement group_id="O3" value="183" lower_limit="61" upper_limit="544"/>
                    <measurement group_id="O4" value="149" lower_limit="43" upper_limit="517"/>
                    <measurement group_id="O5" value="9" lower_limit="3" upper_limit="23"/>
                    <measurement group_id="O6" value="178" lower_limit="95" upper_limit="335"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="104" lower_limit="29" upper_limit="375"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="21" lower_limit="7" upper_limit="60"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134" lower_limit="62" upper_limit="291"/>
                    <measurement group_id="O2" value="112" lower_limit="46" upper_limit="275"/>
                    <measurement group_id="O3" value="130" lower_limit="57" upper_limit="294"/>
                    <measurement group_id="O4" value="131" lower_limit="45" upper_limit="376"/>
                    <measurement group_id="O5" value="11" lower_limit="3" upper_limit="34"/>
                    <measurement group_id="O6" value="140" lower_limit="73" upper_limit="270"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="105" lower_limit="33" upper_limit="329"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="19" lower_limit="7" upper_limit="55"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115" lower_limit="55" upper_limit="243"/>
                    <measurement group_id="O2" value="80" lower_limit="28" upper_limit="224"/>
                    <measurement group_id="O3" value="70" lower_limit="24" upper_limit="202"/>
                    <measurement group_id="O4" value="78" lower_limit="20" upper_limit="310"/>
                    <measurement group_id="O5" value="10" lower_limit="3" upper_limit="29"/>
                    <measurement group_id="O6" value="97" lower_limit="48" upper_limit="198"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="76" lower_limit="23" upper_limit="251"/>
                    <measurement group_id="O9" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O10" value="17" lower_limit="7" upper_limit="42"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2" upper_limit="9"/>
                    <measurement group_id="O2" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O3" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O4" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O5" value="6" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O6" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O7" value="6" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O8" value="6" lower_limit="3" upper_limit="13"/>
                    <measurement group_id="O9" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O10" value="4" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="13" upper_limit="81"/>
                    <measurement group_id="O2" value="15" lower_limit="7" upper_limit="33"/>
                    <measurement group_id="O3" value="11" lower_limit="6" upper_limit="21"/>
                    <measurement group_id="O4" value="16" lower_limit="6" upper_limit="43"/>
                    <measurement group_id="O5" value="6" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O6" value="120" lower_limit="62" upper_limit="231"/>
                    <measurement group_id="O7" value="6" lower_limit="3" upper_limit="11"/>
                    <measurement group_id="O8" value="154" lower_limit="68" upper_limit="348"/>
                    <measurement group_id="O9" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O10" value="35" lower_limit="13" upper_limit="99"/>
                    <measurement group_id="O11" value="3" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="6" upper_limit="47"/>
                    <measurement group_id="O2" value="13" lower_limit="6" upper_limit="26"/>
                    <measurement group_id="O3" value="10" lower_limit="6" upper_limit="19"/>
                    <measurement group_id="O4" value="16" lower_limit="6" upper_limit="43"/>
                    <measurement group_id="O5" value="6" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O6" value="57" lower_limit="36" upper_limit="92"/>
                    <measurement group_id="O7" value="6" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O8" value="78" lower_limit="42" upper_limit="143"/>
                    <measurement group_id="O9" value="6" lower_limit="4" upper_limit="10"/>
                    <measurement group_id="O10" value="24" lower_limit="10" upper_limit="58"/>
                    <measurement group_id="O11" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="6" upper_limit="92"/>
                    <measurement group_id="O2" value="11" lower_limit="6" upper_limit="22"/>
                    <measurement group_id="O3" value="8" lower_limit="5" upper_limit="14"/>
                    <measurement group_id="O4" value="14" lower_limit="4" upper_limit="44"/>
                    <measurement group_id="O5" value="5" lower_limit="2" upper_limit="13"/>
                    <measurement group_id="O6" value="38" lower_limit="22" upper_limit="65"/>
                    <measurement group_id="O7" value="6" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O8" value="53" lower_limit="29" upper_limit="99"/>
                    <measurement group_id="O9" value="7" lower_limit="4" upper_limit="13"/>
                    <measurement group_id="O10" value="16" lower_limit="7" upper_limit="39"/>
                    <measurement group_id="O11" value="3" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="7" upper_limit="63"/>
                    <measurement group_id="O2" value="13" lower_limit="5" upper_limit="34"/>
                    <measurement group_id="O3" value="5" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="O4" value="9" lower_limit="4" upper_limit="20"/>
                    <measurement group_id="O5" value="23" lower_limit="7" upper_limit="70"/>
                    <measurement group_id="O6" value="9" lower_limit="3" upper_limit="29"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="7"/>
                    <measurement group_id="O8" value="9" lower_limit="4" upper_limit="23"/>
                    <measurement group_id="O9" value="6" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O10" value="5" lower_limit="2" upper_limit="9"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140" lower_limit="92" upper_limit="213"/>
                    <measurement group_id="O2" value="193" lower_limit="87" upper_limit="432"/>
                    <measurement group_id="O3" value="57" lower_limit="24" upper_limit="138"/>
                    <measurement group_id="O4" value="52" lower_limit="35" upper_limit="78"/>
                    <measurement group_id="O5" value="18" lower_limit="6" upper_limit="53"/>
                    <measurement group_id="O6" value="92" lower_limit="26" upper_limit="322"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="41" lower_limit="26" upper_limit="65"/>
                    <measurement group_id="O9" value="7" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O10" value="96" lower_limit="22" upper_limit="421"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120" lower_limit="95" upper_limit="151"/>
                    <measurement group_id="O2" value="113" lower_limit="53" upper_limit="239"/>
                    <measurement group_id="O3" value="27" lower_limit="8" upper_limit="93"/>
                    <measurement group_id="O4" value="25" lower_limit="14" upper_limit="42"/>
                    <measurement group_id="O5" value="16" lower_limit="6" upper_limit="45"/>
                    <measurement group_id="O6" value="63" lower_limit="21" upper_limit="186"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O8" value="25" lower_limit="9" upper_limit="70"/>
                    <measurement group_id="O9" value="7" lower_limit="3" upper_limit="16"/>
                    <measurement group_id="O10" value="55" lower_limit="18" upper_limit="170"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116" lower_limit="84" upper_limit="161"/>
                    <measurement group_id="O2" value="68" lower_limit="32" upper_limit="149"/>
                    <measurement group_id="O3" value="19" lower_limit="6" upper_limit="61"/>
                    <measurement group_id="O4" value="19" lower_limit="10" upper_limit="34"/>
                    <measurement group_id="O5" value="19" lower_limit="7" upper_limit="48"/>
                    <measurement group_id="O6" value="42" lower_limit="11" upper_limit="159"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="7"/>
                    <measurement group_id="O8" value="22" lower_limit="9" upper_limit="55"/>
                    <measurement group_id="O9" value="6" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O10" value="39" lower_limit="15" upper_limit="100"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108" lower_limit="73" upper_limit="160"/>
                    <measurement group_id="O2" value="94" lower_limit="44" upper_limit="202"/>
                    <measurement group_id="O3" value="17" lower_limit="6" upper_limit="48"/>
                    <measurement group_id="O4" value="22" lower_limit="10" upper_limit="50"/>
                    <measurement group_id="O5" value="29" lower_limit="12" upper_limit="72"/>
                    <measurement group_id="O6" value="44" lower_limit="12" upper_limit="159"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="22" lower_limit="9" upper_limit="55"/>
                    <measurement group_id="O9" value="7" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O10" value="36" lower_limit="15" upper_limit="89"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108" lower_limit="79" upper_limit="149"/>
                    <measurement group_id="O2" value="76" lower_limit="36" upper_limit="174"/>
                    <measurement group_id="O3" value="19" lower_limit="7" upper_limit="54"/>
                    <measurement group_id="O4" value="19" lower_limit="9" upper_limit="39"/>
                    <measurement group_id="O5" value="30" lower_limit="12" upper_limit="76"/>
                    <measurement group_id="O6" value="34" lower_limit="10" upper_limit="117"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="7"/>
                    <measurement group_id="O8" value="21" lower_limit="9" upper_limit="53"/>
                    <measurement group_id="O9" value="6" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O10" value="31" lower_limit="13" upper_limit="73"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4" upper_limit="17"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="7"/>
                    <measurement group_id="O3" value="4" lower_limit="2" upper_limit="11"/>
                    <measurement group_id="O4" value="8" lower_limit="4" upper_limit="17"/>
                    <measurement group_id="O5" value="5" lower_limit="2" upper_limit="10"/>
                    <measurement group_id="O6" value="9" lower_limit="3" upper_limit="28"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O8" value="18" lower_limit="5" upper_limit="66"/>
                    <measurement group_id="O9" value="8" lower_limit="4" upper_limit="17"/>
                    <measurement group_id="O10" value="5" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="O11" value="7" lower_limit="3" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39" lower_limit="22" upper_limit="71"/>
                    <measurement group_id="O2" value="32" lower_limit="17" upper_limit="60"/>
                    <measurement group_id="O3" value="17" lower_limit="7" upper_limit="42"/>
                    <measurement group_id="O4" value="19" lower_limit="12" upper_limit="31"/>
                    <measurement group_id="O5" value="7" lower_limit="3" upper_limit="20"/>
                    <measurement group_id="O6" value="38" lower_limit="11" upper_limit="125"/>
                    <measurement group_id="O7" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O8" value="44" lower_limit="13" upper_limit="144"/>
                    <measurement group_id="O9" value="8" lower_limit="4" upper_limit="19"/>
                    <measurement group_id="O10" value="42" lower_limit="20" upper_limit="89"/>
                    <measurement group_id="O11" value="7" lower_limit="3" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="11" upper_limit="54"/>
                    <measurement group_id="O2" value="20" lower_limit="9" upper_limit="44"/>
                    <measurement group_id="O3" value="9" lower_limit="4" upper_limit="23"/>
                    <measurement group_id="O4" value="14" lower_limit="7" upper_limit="28"/>
                    <measurement group_id="O5" value="6" lower_limit="3" upper_limit="15"/>
                    <measurement group_id="O6" value="27" lower_limit="9" upper_limit="83"/>
                    <measurement group_id="O7" value="6" lower_limit="3" upper_limit="11"/>
                    <measurement group_id="O8" value="29" lower_limit="10" upper_limit="85"/>
                    <measurement group_id="O9" value="9" lower_limit="4" upper_limit="19"/>
                    <measurement group_id="O10" value="25" lower_limit="10" upper_limit="65"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="5" upper_limit="45"/>
                    <measurement group_id="O2" value="13" lower_limit="5" upper_limit="38"/>
                    <measurement group_id="O3" value="8" lower_limit="3" upper_limit="22"/>
                    <measurement group_id="O4" value="16" lower_limit="9" upper_limit="29"/>
                    <measurement group_id="O5" value="6" lower_limit="3" upper_limit="11"/>
                    <measurement group_id="O6" value="17" lower_limit="5" upper_limit="56"/>
                    <measurement group_id="O7" value="7" lower_limit="3" upper_limit="18"/>
                    <measurement group_id="O8" value="24" lower_limit="9" upper_limit="66"/>
                    <measurement group_id="O9" value="11" lower_limit="4" upper_limit="28"/>
                    <measurement group_id="O10" value="19" lower_limit="7" upper_limit="47"/>
                    <measurement group_id="O11" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgG</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: predose 1 and 7, 21, 28 days PD1, and 7 and 28 days PD2; II run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgG</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="3" upper_limit="55"/>
                    <measurement group_id="O2" value="8" lower_limit="2" upper_limit="27"/>
                    <measurement group_id="O3" value="28" lower_limit="11" upper_limit="73"/>
                    <measurement group_id="O4" value="22" lower_limit="7" upper_limit="68"/>
                    <measurement group_id="O5" value="9" lower_limit="2" upper_limit="37"/>
                    <measurement group_id="O6" value="9" lower_limit="3" upper_limit="26"/>
                    <measurement group_id="O7" value="7" lower_limit="3" upper_limit="21"/>
                    <measurement group_id="O8" value="14" lower_limit="5" upper_limit="38"/>
                    <measurement group_id="O9" value="11" lower_limit="4" upper_limit="26"/>
                    <measurement group_id="O10" value="7" lower_limit="2" upper_limit="32"/>
                    <measurement group_id="O11" value="5" lower_limit="1" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="211" lower_limit="98" upper_limit="452"/>
                    <measurement group_id="O2" value="237" lower_limit="120" upper_limit="466"/>
                    <measurement group_id="O3" value="1650" lower_limit="673" upper_limit="4047"/>
                    <measurement group_id="O4" value="1171" lower_limit="251" upper_limit="5457"/>
                    <measurement group_id="O5" value="5" lower_limit="1" upper_limit="20"/>
                    <measurement group_id="O6" value="375" lower_limit="97" upper_limit="1447"/>
                    <measurement group_id="O7" value="7" lower_limit="2" upper_limit="19"/>
                    <measurement group_id="O8" value="96" lower_limit="32" upper_limit="289"/>
                    <measurement group_id="O9" value="10" lower_limit="4" upper_limit="24"/>
                    <measurement group_id="O10" value="82" lower_limit="18" upper_limit="373"/>
                    <measurement group_id="O11" value="5" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="266" lower_limit="130" upper_limit="545"/>
                    <measurement group_id="O2" value="184" lower_limit="93" upper_limit="363"/>
                    <measurement group_id="O3" value="1165" lower_limit="495" upper_limit="2741"/>
                    <measurement group_id="O4" value="1235" lower_limit="534" upper_limit="2858"/>
                    <measurement group_id="O5" value="7" lower_limit="2" upper_limit="26"/>
                    <measurement group_id="O6" value="457" lower_limit="159" upper_limit="1312"/>
                    <measurement group_id="O7" value="5" lower_limit="1" upper_limit="18"/>
                    <measurement group_id="O8" value="97" lower_limit="30" upper_limit="309"/>
                    <measurement group_id="O9" value="13" lower_limit="5" upper_limit="30"/>
                    <measurement group_id="O10" value="107" lower_limit="24" upper_limit="468"/>
                    <measurement group_id="O11" value="5" lower_limit="1" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="261" lower_limit="140" upper_limit="486"/>
                    <measurement group_id="O2" value="152" lower_limit="76" upper_limit="305"/>
                    <measurement group_id="O3" value="910" lower_limit="379" upper_limit="2185"/>
                    <measurement group_id="O4" value="878" lower_limit="409" upper_limit="1882"/>
                    <measurement group_id="O5" value="7" lower_limit="2" upper_limit="26"/>
                    <measurement group_id="O6" value="429" lower_limit="178" upper_limit="1036"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O8" value="110" lower_limit="41" upper_limit="300"/>
                    <measurement group_id="O9" value="10" lower_limit="4" upper_limit="23"/>
                    <measurement group_id="O10" value="93" lower_limit="22" upper_limit="395"/>
                    <measurement group_id="O11" value="5" lower_limit="2" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="281" lower_limit="152" upper_limit="520"/>
                    <measurement group_id="O2" value="167" lower_limit="77" upper_limit="365"/>
                    <measurement group_id="O3" value="723" lower_limit="360" upper_limit="1452"/>
                    <measurement group_id="O4" value="957" lower_limit="554" upper_limit="1651"/>
                    <measurement group_id="O5" value="10" lower_limit="2" upper_limit="49"/>
                    <measurement group_id="O6" value="513" lower_limit="249" upper_limit="1060"/>
                    <measurement group_id="O7" value="7" lower_limit="3" upper_limit="21"/>
                    <measurement group_id="O8" value="157" lower_limit="66" upper_limit="373"/>
                    <measurement group_id="O9" value="10" lower_limit="4" upper_limit="24"/>
                    <measurement group_id="O10" value="108" lower_limit="25" upper_limit="474"/>
                    <measurement group_id="O11" value="5" lower_limit="2" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="286" lower_limit="151" upper_limit="540"/>
                    <measurement group_id="O2" value="168" lower_limit="76" upper_limit="346"/>
                    <measurement group_id="O3" value="605" lower_limit="256" upper_limit="1432"/>
                    <measurement group_id="O4" value="737" lower_limit="399" upper_limit="1361"/>
                    <measurement group_id="O5" value="11" lower_limit="2" upper_limit="50"/>
                    <measurement group_id="O6" value="518" lower_limit="278" upper_limit="966"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="19"/>
                    <measurement group_id="O8" value="177" lower_limit="78" upper_limit="399"/>
                    <measurement group_id="O9" value="10" lower_limit="4" upper_limit="26"/>
                    <measurement group_id="O10" value="127" lower_limit="27" upper_limit="586"/>
                    <measurement group_id="O11" value="5" lower_limit="2" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O2" value="7" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O3" value="5" lower_limit="3" upper_limit="8"/>
                    <measurement group_id="O4" value="5" lower_limit="2" upper_limit="10"/>
                    <measurement group_id="O5" value="7" lower_limit="2" upper_limit="27"/>
                    <measurement group_id="O6" value="8" lower_limit="4" upper_limit="19"/>
                    <measurement group_id="O7" value="7" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O8" value="9" lower_limit="3" upper_limit="30"/>
                    <measurement group_id="O9" value="8" lower_limit="4" upper_limit="18"/>
                    <measurement group_id="O10" value="3" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="O11" value="3" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="45" upper_limit="156"/>
                    <measurement group_id="O2" value="94" lower_limit="46" upper_limit="192"/>
                    <measurement group_id="O3" value="89" lower_limit="44" upper_limit="181"/>
                    <measurement group_id="O4" value="113" lower_limit="78" upper_limit="164"/>
                    <measurement group_id="O5" value="10" lower_limit="3" upper_limit="36"/>
                    <measurement group_id="O6" value="270" lower_limit="178" upper_limit="411"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O8" value="103" lower_limit="53" upper_limit="200"/>
                    <measurement group_id="O9" value="8" lower_limit="4" upper_limit="17"/>
                    <measurement group_id="O10" value="80" lower_limit="56" upper_limit="116"/>
                    <measurement group_id="O11" value="3" lower_limit="1" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="22" upper_limit="91"/>
                    <measurement group_id="O2" value="65" lower_limit="43" upper_limit="99"/>
                    <measurement group_id="O3" value="46" lower_limit="24" upper_limit="89"/>
                    <measurement group_id="O4" value="73" lower_limit="45" upper_limit="118"/>
                    <measurement group_id="O5" value="8" lower_limit="2" upper_limit="28"/>
                    <measurement group_id="O6" value="135" lower_limit="90" upper_limit="202"/>
                    <measurement group_id="O7" value="7" lower_limit="3" upper_limit="16"/>
                    <measurement group_id="O8" value="82" lower_limit="47" upper_limit="143"/>
                    <measurement group_id="O9" value="8" lower_limit="4" upper_limit="17"/>
                    <measurement group_id="O10" value="35" lower_limit="27" upper_limit="44"/>
                    <measurement group_id="O11" value="3" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" lower_limit="26" upper_limit="131"/>
                    <measurement group_id="O2" value="53" lower_limit="40" upper_limit="68"/>
                    <measurement group_id="O3" value="28" lower_limit="15" upper_limit="54"/>
                    <measurement group_id="O4" value="46" lower_limit="23" upper_limit="92"/>
                    <measurement group_id="O5" value="6" lower_limit="2" upper_limit="19"/>
                    <measurement group_id="O6" value="75" lower_limit="55" upper_limit="103"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="O8" value="57" lower_limit="33" upper_limit="99"/>
                    <measurement group_id="O9" value="10" lower_limit="4" upper_limit="28"/>
                    <measurement group_id="O10" value="21" lower_limit="13" upper_limit="34"/>
                    <measurement group_id="O11" value="3" lower_limit="1" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" lower_limit="10" upper_limit="142"/>
                    <measurement group_id="O2" value="19" lower_limit="6" upper_limit="62"/>
                    <measurement group_id="O3" value="5" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O4" value="17" lower_limit="7" upper_limit="41"/>
                    <measurement group_id="O5" value="19" lower_limit="5" upper_limit="69"/>
                    <measurement group_id="O6" value="8" lower_limit="2" upper_limit="29"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O8" value="10" lower_limit="4" upper_limit="28"/>
                    <measurement group_id="O9" value="6" lower_limit="2" upper_limit="20"/>
                    <measurement group_id="O10" value="11" lower_limit="5" upper_limit="22"/>
                    <measurement group_id="O11" value="13" lower_limit="4" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="56" upper_limit="167"/>
                    <measurement group_id="O2" value="136" lower_limit="66" upper_limit="279"/>
                    <measurement group_id="O3" value="43" lower_limit="30" upper_limit="62"/>
                    <measurement group_id="O4" value="40" lower_limit="27" upper_limit="60"/>
                    <measurement group_id="O5" value="14" lower_limit="4" upper_limit="53"/>
                    <measurement group_id="O6" value="54" lower_limit="14" upper_limit="206"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O8" value="23" lower_limit="14" upper_limit="37"/>
                    <measurement group_id="O9" value="9" lower_limit="3" upper_limit="24"/>
                    <measurement group_id="O10" value="178" lower_limit="100" upper_limit="317"/>
                    <measurement group_id="O11" value="16" lower_limit="6" upper_limit="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142" lower_limit="70" upper_limit="286"/>
                    <measurement group_id="O2" value="128" lower_limit="59" upper_limit="279"/>
                    <measurement group_id="O3" value="35" lower_limit="25" upper_limit="50"/>
                    <measurement group_id="O4" value="39" lower_limit="27" upper_limit="55"/>
                    <measurement group_id="O5" value="13" lower_limit="4" upper_limit="45"/>
                    <measurement group_id="O6" value="93" lower_limit="33" upper_limit="262"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O8" value="29" lower_limit="17" upper_limit="49"/>
                    <measurement group_id="O9" value="9" lower_limit="3" upper_limit="28"/>
                    <measurement group_id="O10" value="180" lower_limit="126" upper_limit="259"/>
                    <measurement group_id="O11" value="17" lower_limit="6" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139" lower_limit="73" upper_limit="267"/>
                    <measurement group_id="O2" value="98" lower_limit="42" upper_limit="225"/>
                    <measurement group_id="O3" value="31" lower_limit="22" upper_limit="45"/>
                    <measurement group_id="O4" value="37" lower_limit="28" upper_limit="49"/>
                    <measurement group_id="O5" value="16" lower_limit="6" upper_limit="46"/>
                    <measurement group_id="O6" value="86" lower_limit="31" upper_limit="237"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="13"/>
                    <measurement group_id="O8" value="30" lower_limit="20" upper_limit="45"/>
                    <measurement group_id="O9" value="7" lower_limit="2" upper_limit="20"/>
                    <measurement group_id="O10" value="148" lower_limit="105" upper_limit="208"/>
                    <measurement group_id="O11" value="16" lower_limit="6" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144" lower_limit="72" upper_limit="288"/>
                    <measurement group_id="O2" value="132" lower_limit="71" upper_limit="248"/>
                    <measurement group_id="O3" value="34" lower_limit="28" upper_limit="42"/>
                    <measurement group_id="O4" value="42" lower_limit="34" upper_limit="51"/>
                    <measurement group_id="O5" value="25" lower_limit="9" upper_limit="69"/>
                    <measurement group_id="O6" value="99" lower_limit="42" upper_limit="233"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O8" value="34" lower_limit="25" upper_limit="45"/>
                    <measurement group_id="O9" value="8" lower_limit="3" upper_limit="24"/>
                    <measurement group_id="O10" value="144" lower_limit="106" upper_limit="196"/>
                    <measurement group_id="O11" value="15" lower_limit="5" upper_limit="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174" lower_limit="90" upper_limit="336"/>
                    <measurement group_id="O2" value="125" lower_limit="72" upper_limit="218"/>
                    <measurement group_id="O3" value="34" lower_limit="26" upper_limit="46"/>
                    <measurement group_id="O4" value="41" lower_limit="32" upper_limit="51"/>
                    <measurement group_id="O5" value="27" lower_limit="10" upper_limit="75"/>
                    <measurement group_id="O6" value="102" lower_limit="43" upper_limit="242"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O8" value="36" lower_limit="28" upper_limit="47"/>
                    <measurement group_id="O9" value="7" lower_limit="3" upper_limit="21"/>
                    <measurement group_id="O10" value="140" lower_limit="97" upper_limit="202"/>
                    <measurement group_id="O11" value="17" lower_limit="6" upper_limit="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="5" upper_limit="31"/>
                    <measurement group_id="O2" value="11" lower_limit="4" upper_limit="32"/>
                    <measurement group_id="O3" value="5" lower_limit="2" upper_limit="13"/>
                    <measurement group_id="O4" value="10" lower_limit="3" upper_limit="33"/>
                    <measurement group_id="O5" value="5" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O6" value="6" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O7" value="4" lower_limit="2" upper_limit="9"/>
                    <measurement group_id="O8" value="9" lower_limit="2" upper_limit="42"/>
                    <measurement group_id="O9" value="7" lower_limit="2" upper_limit="20"/>
                    <measurement group_id="O10" value="3" lower_limit="1" upper_limit="7"/>
                    <measurement group_id="O11" value="6" lower_limit="2" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="39" upper_limit="106"/>
                    <measurement group_id="O2" value="74" lower_limit="46" upper_limit="120"/>
                    <measurement group_id="O3" value="57" lower_limit="35" upper_limit="91"/>
                    <measurement group_id="O4" value="37" lower_limit="18" upper_limit="73"/>
                    <measurement group_id="O5" value="8" lower_limit="2" upper_limit="34"/>
                    <measurement group_id="O6" value="104" lower_limit="65" upper_limit="166"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="O8" value="52" lower_limit="22" upper_limit="120"/>
                    <measurement group_id="O9" value="7" lower_limit="2" upper_limit="18"/>
                    <measurement group_id="O10" value="37" lower_limit="25" upper_limit="56"/>
                    <measurement group_id="O11" value="6" lower_limit="2" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="31" upper_limit="87"/>
                    <measurement group_id="O2" value="44" lower_limit="22" upper_limit="91"/>
                    <measurement group_id="O3" value="18" lower_limit="8" upper_limit="41"/>
                    <measurement group_id="O4" value="18" lower_limit="9" upper_limit="36"/>
                    <measurement group_id="O5" value="7" lower_limit="2" upper_limit="23"/>
                    <measurement group_id="O6" value="77" lower_limit="30" upper_limit="194"/>
                    <measurement group_id="O7" value="5" lower_limit="2" upper_limit="11"/>
                    <measurement group_id="O8" value="33" lower_limit="14" upper_limit="75"/>
                    <measurement group_id="O9" value="8" lower_limit="2" upper_limit="26"/>
                    <measurement group_id="O10" value="20" lower_limit="12" upper_limit="33"/>
                    <measurement group_id="O11" value="5" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="11" upper_limit="75"/>
                    <measurement group_id="O2" value="51" lower_limit="27" upper_limit="96"/>
                    <measurement group_id="O3" value="13" lower_limit="7" upper_limit="25"/>
                    <measurement group_id="O4" value="23" lower_limit="11" upper_limit="51"/>
                    <measurement group_id="O5" value="6" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="O6" value="44" lower_limit="24" upper_limit="81"/>
                    <measurement group_id="O7" value="6" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="O8" value="22" lower_limit="9" upper_limit="54"/>
                    <measurement group_id="O9" value="13" lower_limit="5" upper_limit="34"/>
                    <measurement group_id="O10" value="16" lower_limit="8" upper_limit="34"/>
                    <measurement group_id="O11" value="5" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgM</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: predose 1 and 7, 21, 28 days PD1, and 7 and 28 days PD2; II run: predose 1 and 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMT of Serum Anti-norovirus GI.1 and GII.4 VLP IgM</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Rise (GMFR) of Serum Anti-norovirus GI.1 and GII.4 VLP IgA as Compared to Baseline</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Rise (GMFR) of Serum Anti-norovirus GI.1 and GII.4 VLP IgA as Compared to Baseline</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>fold rise</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1" lower_limit="7.4" upper_limit="71.9"/>
                    <measurement group_id="O2" value="76.1" lower_limit="38.1" upper_limit="152"/>
                    <measurement group_id="O3" value="84.4" lower_limit="20.6" upper_limit="345.1"/>
                    <measurement group_id="O4" value="122.9" lower_limit="30" upper_limit="503.7"/>
                    <measurement group_id="O5" value="0.8" lower_limit="0.3" upper_limit="1.8"/>
                    <measurement group_id="O6" value="115.2" lower_limit="35.5" upper_limit="373.7"/>
                    <measurement group_id="O7" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O8" value="39.1" lower_limit="10.3" upper_limit="148.2"/>
                    <measurement group_id="O9" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O10" value="12.6" lower_limit="4.2" upper_limit="37.6"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" lower_limit="7" upper_limit="49"/>
                    <measurement group_id="O2" value="34.9" lower_limit="16.6" upper_limit="73.4"/>
                    <measurement group_id="O3" value="49.6" lower_limit="18.2" upper_limit="134.9"/>
                    <measurement group_id="O4" value="52.1" lower_limit="19.3" upper_limit="140.4"/>
                    <measurement group_id="O5" value="1" lower_limit="0.9" upper_limit="1.2"/>
                    <measurement group_id="O6" value="81.2" lower_limit="48.6" upper_limit="135.7"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="24.2" lower_limit="6.9" upper_limit="85.7"/>
                    <measurement group_id="O9" value="1" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O10" value="9.7" lower_limit="3.1" upper_limit="30.2"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2" lower_limit="6.1" upper_limit="42.8"/>
                    <measurement group_id="O2" value="22.6" lower_limit="11.1" upper_limit="46"/>
                    <measurement group_id="O3" value="33.7" lower_limit="11.7" upper_limit="46"/>
                    <measurement group_id="O4" value="25.4" lower_limit="10.5" upper_limit="61.3"/>
                    <measurement group_id="O5" value="1" lower_limit="0.8" upper_limit="1.2"/>
                    <measurement group_id="O6" value="57.5" lower_limit="30.6" upper_limit="108"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="19.6" lower_limit="6.4" upper_limit="60.5"/>
                    <measurement group_id="O9" value="1" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O10" value="6.6" lower_limit="2.4" upper_limit="18.8"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1" lower_limit="6.2" upper_limit="37"/>
                    <measurement group_id="O2" value="22.5" lower_limit="11.8" upper_limit="42.9"/>
                    <measurement group_id="O3" value="23.9" lower_limit="9.6" upper_limit="59.7"/>
                    <measurement group_id="O4" value="22.2" lower_limit="10.8" upper_limit="45.4"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.7" upper_limit="1.6"/>
                    <measurement group_id="O6" value="45.2" lower_limit="23.4" upper_limit="87.2"/>
                    <measurement group_id="O7" value="1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O8" value="19.7" lower_limit="7.3" upper_limit="53.2"/>
                    <measurement group_id="O9" value="1" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O10" value="6" lower_limit="2.1" upper_limit="17.3"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="5" upper_limit="33.6"/>
                    <measurement group_id="O2" value="16" lower_limit="7.4" upper_limit="34.5"/>
                    <measurement group_id="O3" value="12.1" lower_limit="4.8" upper_limit="30.7"/>
                    <measurement group_id="O4" value="13.2" lower_limit="5" upper_limit="34.7"/>
                    <measurement group_id="O5" value="1" lower_limit="0.7" upper_limit="1.3"/>
                    <measurement group_id="O6" value="31.3" lower_limit="15.4" upper_limit="63.7"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.9" upper_limit="1.3"/>
                    <measurement group_id="O8" value="14.2" lower_limit="5.1" upper_limit="39.8"/>
                    <measurement group_id="O9" value="1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O10" value="5.3" lower_limit="2.1" upper_limit="13.1"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3.7" upper_limit="13.3"/>
                    <measurement group_id="O2" value="5" lower_limit="2.3" upper_limit="10.7"/>
                    <measurement group_id="O3" value="3.6" lower_limit="1.9" upper_limit="6.8"/>
                    <measurement group_id="O4" value="4.7" lower_limit="1.9" upper_limit="11.7"/>
                    <measurement group_id="O5" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O6" value="38.6" lower_limit="19.9" upper_limit="74.6"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="25.5" lower_limit="9.1" upper_limit="71.4"/>
                    <measurement group_id="O9" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O10" value="9.6" lower_limit="3.7" upper_limit="24.9"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" lower_limit="1.8" upper_limit="7.1"/>
                    <measurement group_id="O2" value="4.1" lower_limit="2" upper_limit="8.3"/>
                    <measurement group_id="O3" value="3.3" lower_limit="1.8" upper_limit="6"/>
                    <measurement group_id="O4" value="4.6" lower_limit="1.7" upper_limit="12"/>
                    <measurement group_id="O5" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O6" value="18.5" lower_limit="11.5" upper_limit="29.8"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.9" upper_limit="1.3"/>
                    <measurement group_id="O8" value="12.9" lower_limit="5.5" upper_limit="30"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.9" upper_limit="1.3"/>
                    <measurement group_id="O10" value="6.6" lower_limit="2.9" upper_limit="15.1"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" lower_limit="1.3" upper_limit="13.5"/>
                    <measurement group_id="O2" value="3.7" lower_limit="1.9" upper_limit="7.1"/>
                    <measurement group_id="O3" value="2.6" lower_limit="1.6" upper_limit="4.4"/>
                    <measurement group_id="O4" value="4.5" lower_limit="1.4" upper_limit="14.1"/>
                    <measurement group_id="O5" value="1" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O6" value="12.2" lower_limit="7.1" upper_limit="20.9"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.2"/>
                    <measurement group_id="O8" value="8.8" lower_limit="3.9" upper_limit="20.2"/>
                    <measurement group_id="O9" value="1.3" lower_limit="0.9" upper_limit="1.9"/>
                    <measurement group_id="O10" value="5.2" lower_limit="2.1" upper_limit="12.7"/>
                    <measurement group_id="O11" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" lower_limit="2.2" upper_limit="20.7"/>
                    <measurement group_id="O2" value="15.4" lower_limit="4.7" upper_limit="50.8"/>
                    <measurement group_id="O3" value="10.7" lower_limit="3.5" upper_limit="32.9"/>
                    <measurement group_id="O4" value="5" lower_limit="2.2" upper_limit="11"/>
                    <measurement group_id="O5" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O6" value="9.7" lower_limit="3" upper_limit="30.6"/>
                    <measurement group_id="O7" value="1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O8" value="4.4" lower_limit="2.1" upper_limit="9.6"/>
                    <measurement group_id="O9" value="1.2" lower_limit="0.9" upper_limit="1.4"/>
                    <measurement group_id="O10" value="19.9" lower_limit="5.9" upper_limit="67.6"/>
                    <measurement group_id="O11" value="1" lower_limit="1" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" lower_limit="2" upper_limit="16.5"/>
                    <measurement group_id="O2" value="9" lower_limit="4.1" upper_limit="20"/>
                    <measurement group_id="O3" value="5" lower_limit="1.3" upper_limit="18.9"/>
                    <measurement group_id="O4" value="2.7" lower_limit="1.3" upper_limit="5.5"/>
                    <measurement group_id="O5" value="0.9" lower_limit="0.7" upper_limit="1"/>
                    <measurement group_id="O6" value="6.6" lower_limit="3" upper_limit="14.4"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.9" upper_limit="1.2"/>
                    <measurement group_id="O8" value="3.5" lower_limit="1.2" upper_limit="9.7"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.8" upper_limit="1.6"/>
                    <measurement group_id="O10" value="11.4" lower_limit="3.9" upper_limit="33.3"/>
                    <measurement group_id="O11" value="1" lower_limit="1" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="2.1" upper_limit="14.8"/>
                    <measurement group_id="O2" value="5.5" lower_limit="2.4" upper_limit="12.3"/>
                    <measurement group_id="O3" value="3.6" lower_limit="1.1" upper_limit="12"/>
                    <measurement group_id="O4" value="2" lower_limit="1" upper_limit="4.3"/>
                    <measurement group_id="O5" value="1" lower_limit="0.6" upper_limit="1.9"/>
                    <measurement group_id="O6" value="4.5" lower_limit="1.9" upper_limit="10.7"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.9" upper_limit="6.4"/>
                    <measurement group_id="O9" value="1" lower_limit="0.8" upper_limit="1.2"/>
                    <measurement group_id="O10" value="8.1" lower_limit="3.2" upper_limit="20.4"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="2.1" upper_limit="12.6"/>
                    <measurement group_id="O2" value="6.1" lower_limit="2.9" upper_limit="12.7"/>
                    <measurement group_id="O3" value="3.2" lower_limit="1.1" upper_limit="9.4"/>
                    <measurement group_id="O4" value="2.5" lower_limit="1" upper_limit="5.9"/>
                    <measurement group_id="O5" value="1.3" lower_limit="0.4" upper_limit="3.6"/>
                    <measurement group_id="O6" value="4.6" lower_limit="2.1" upper_limit="10.3"/>
                    <measurement group_id="O7" value="1.1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.9" upper_limit="6.3"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.9" upper_limit="1.5"/>
                    <measurement group_id="O10" value="7.5" lower_limit="3" upper_limit="18.6"/>
                    <measurement group_id="O11" value="1" lower_limit="0.8" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="2.1" upper_limit="12.6"/>
                    <measurement group_id="O2" value="5.2" lower_limit="2.6" upper_limit="10.2"/>
                    <measurement group_id="O3" value="3.4" lower_limit="1.4" upper_limit="8.4"/>
                    <measurement group_id="O4" value="2" lower_limit="1" upper_limit="4.4"/>
                    <measurement group_id="O5" value="1.3" lower_limit="0.5" upper_limit="3.3"/>
                    <measurement group_id="O6" value="3.5" lower_limit="1.7" upper_limit="7.4"/>
                    <measurement group_id="O7" value="1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O8" value="2.3" lower_limit="1" upper_limit="5.7"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                    <measurement group_id="O10" value="6.4" lower_limit="2.6" upper_limit="15.6"/>
                    <measurement group_id="O11" value="1.1" lower_limit="1" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" lower_limit="2.9" upper_limit="7.7"/>
                    <measurement group_id="O2" value="7.5" lower_limit="4.6" upper_limit="12.2"/>
                    <measurement group_id="O3" value="3.9" lower_limit="1.6" upper_limit="9.1"/>
                    <measurement group_id="O4" value="2.5" lower_limit="1" upper_limit="5.9"/>
                    <measurement group_id="O5" value="1.5" lower_limit="0.6" upper_limit="3.6"/>
                    <measurement group_id="O6" value="4" lower_limit="1.9" upper_limit="8.3"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.8" upper_limit="7.2"/>
                    <measurement group_id="O9" value="1" lower_limit="0.9" upper_limit="1.2"/>
                    <measurement group_id="O10" value="8.1" lower_limit="3.2" upper_limit="20.4"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" lower_limit="1.8" upper_limit="3.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="2.4" upper_limit="9.4"/>
                    <measurement group_id="O3" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.8" upper_limit="4.5"/>
                    <measurement group_id="O5" value="1.3" lower_limit="0.7" upper_limit="2.4"/>
                    <measurement group_id="O6" value="2.8" lower_limit="1.5" upper_limit="5.2"/>
                    <measurement group_id="O7" value="1.2" lower_limit="0.9" upper_limit="1.6"/>
                    <measurement group_id="O8" value="1.6" lower_limit="0.5" upper_limit="4.8"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                    <measurement group_id="O10" value="4.8" lower_limit="1.8" upper_limit="12.7"/>
                    <measurement group_id="O11" value="0.8" lower_limit="0.6" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1.2" upper_limit="3.2"/>
                    <measurement group_id="O2" value="3.1" lower_limit="1.3" upper_limit="7.3"/>
                    <measurement group_id="O3" value="1.7" lower_limit="0.9" upper_limit="3.5"/>
                    <measurement group_id="O4" value="1.8" lower_limit="0.8" upper_limit="4.2"/>
                    <measurement group_id="O5" value="1.3" lower_limit="0.8" upper_limit="2.1"/>
                    <measurement group_id="O6" value="1.8" lower_limit="0.9" upper_limit="3.6"/>
                    <measurement group_id="O7" value="1.5" lower_limit="0.9" upper_limit="2.6"/>
                    <measurement group_id="O8" value="1.3" lower_limit="0.4" upper_limit="4.1"/>
                    <measurement group_id="O9" value="1.4" lower_limit="0.8" upper_limit="2.3"/>
                    <measurement group_id="O10" value="4.4" lower_limit="1.6" upper_limit="12"/>
                    <measurement group_id="O11" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgG as Compared to Baseline</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgG as Compared to Baseline</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>fold rise</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2" lower_limit="3.8" upper_limit="68.7"/>
                    <measurement group_id="O2" value="29.4" lower_limit="11.2" upper_limit="77.2"/>
                    <measurement group_id="O3" value="59.5" lower_limit="27.2" upper_limit="130.2"/>
                    <measurement group_id="O4" value="54.9" lower_limit="17.6" upper_limit="171"/>
                    <measurement group_id="O5" value="0.7" lower_limit="0.2" upper_limit="2"/>
                    <measurement group_id="O6" value="43" lower_limit="5.9" upper_limit="315.7"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.6" upper_limit="1.4"/>
                    <measurement group_id="O8" value="6.8" lower_limit="2.3" upper_limit="20.8"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.8" upper_limit="1"/>
                    <measurement group_id="O10" value="11.2" lower_limit="2.4" upper_limit="52.4"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.5" lower_limit="5.2" upper_limit="80.2"/>
                    <measurement group_id="O2" value="22.8" lower_limit="8.7" upper_limit="59.8"/>
                    <measurement group_id="O3" value="42" lower_limit="22.6" upper_limit="78.3"/>
                    <measurement group_id="O4" value="55.2" lower_limit="25.7" upper_limit="118.7"/>
                    <measurement group_id="O5" value="1" lower_limit="0.8" upper_limit="1.2"/>
                    <measurement group_id="O6" value="52.5" lower_limit="10.2" upper_limit="270.8"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.5" upper_limit="1.2"/>
                    <measurement group_id="O8" value="7.5" lower_limit="2.4" upper_limit="23.1"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.8" upper_limit="1.1"/>
                    <measurement group_id="O10" value="14.4" lower_limit="2.9" upper_limit="71.8"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="4.9" upper_limit="81.6"/>
                    <measurement group_id="O2" value="18.9" lower_limit="6.8" upper_limit="52.6"/>
                    <measurement group_id="O3" value="32.8" lower_limit="18.2" upper_limit="59.2"/>
                    <measurement group_id="O4" value="39.2" lower_limit="17.6" upper_limit="87.6"/>
                    <measurement group_id="O5" value="1" lower_limit="0.8" upper_limit="1.2"/>
                    <measurement group_id="O6" value="49.3" lower_limit="11.2" upper_limit="217.8"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.5" upper_limit="1.3"/>
                    <measurement group_id="O8" value="7.9" lower_limit="3.1" upper_limit="20.4"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.8" upper_limit="1"/>
                    <measurement group_id="O10" value="12.7" lower_limit="2.7" upper_limit="59.3"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" lower_limit="5.4" upper_limit="86.1"/>
                    <measurement group_id="O2" value="23.8" lower_limit="9" upper_limit="63.2"/>
                    <measurement group_id="O3" value="26.1" lower_limit="15.2" upper_limit="44.8"/>
                    <measurement group_id="O4" value="42.8" lower_limit="17.4" upper_limit="104.8"/>
                    <measurement group_id="O5" value="1.2" lower_limit="0.7" upper_limit="2.1"/>
                    <measurement group_id="O6" value="59" lower_limit="14.4" upper_limit="241"/>
                    <measurement group_id="O7" value="1" lower_limit="0.6" upper_limit="1.7"/>
                    <measurement group_id="O8" value="11.3" lower_limit="4.3" upper_limit="29.8"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.8" upper_limit="1"/>
                    <measurement group_id="O10" value="14.7" lower_limit="3.1" upper_limit="70.3"/>
                    <measurement group_id="O11" value="1" lower_limit="0.8" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="5.6" upper_limit="86.3"/>
                    <measurement group_id="O2" value="23.1" lower_limit="8.8" upper_limit="60.6"/>
                    <measurement group_id="O3" value="19.7" lower_limit="11.8" upper_limit="32.9"/>
                    <measurement group_id="O4" value="32.9" lower_limit="14.6" upper_limit="74.5"/>
                    <measurement group_id="O5" value="1.2" lower_limit="0.8" upper_limit="1.9"/>
                    <measurement group_id="O6" value="59.5" lower_limit="16.9" upper_limit="209.6"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.5" upper_limit="1.5"/>
                    <measurement group_id="O8" value="12.6" lower_limit="4.9" upper_limit="32.8"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O10" value="17.2" lower_limit="3.6" upper_limit="82.7"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="4.9" upper_limit="59.2"/>
                    <measurement group_id="O2" value="14.1" lower_limit="7.9" upper_limit="25.3"/>
                    <measurement group_id="O3" value="18.8" lower_limit="9.3" upper_limit="37.9"/>
                    <measurement group_id="O4" value="23.9" lower_limit="14.4" upper_limit="39.7"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.8" upper_limit="2.5"/>
                    <measurement group_id="O6" value="32" lower_limit="14.5" upper_limit="70.5"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1.3"/>
                    <measurement group_id="O8" value="10.9" lower_limit="3.8" upper_limit="31"/>
                    <measurement group_id="O9" value="1" lower_limit="0.8" upper_limit="1.2"/>
                    <measurement group_id="O10" value="26.6" lower_limit="11.2" upper_limit="63"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" lower_limit="2.3" upper_limit="26.6"/>
                    <measurement group_id="O2" value="9.8" lower_limit="5.2" upper_limit="18.5"/>
                    <measurement group_id="O3" value="9.6" lower_limit="5.1" upper_limit="18"/>
                    <measurement group_id="O4" value="15.5" lower_limit="7.1" upper_limit="33.9"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.7" upper_limit="1.9"/>
                    <measurement group_id="O6" value="15.9" lower_limit="6.5" upper_limit="38.9"/>
                    <measurement group_id="O7" value="1" lower_limit="0.7" upper_limit="1.4"/>
                    <measurement group_id="O8" value="8.7" lower_limit="3.3" upper_limit="22.7"/>
                    <measurement group_id="O9" value="1" lower_limit="0.7" upper_limit="1.3"/>
                    <measurement group_id="O10" value="11.5" lower_limit="5.1" upper_limit="26"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.6" upper_limit="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" lower_limit="1.7" upper_limit="49.5"/>
                    <measurement group_id="O2" value="7.9" lower_limit="4.1" upper_limit="14.9"/>
                    <measurement group_id="O3" value="6.1" lower_limit="3.6" upper_limit="10.4"/>
                    <measurement group_id="O4" value="11.7" lower_limit="5" upper_limit="27.4"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.6" upper_limit="2.1"/>
                    <measurement group_id="O6" value="8.9" lower_limit="4.1" upper_limit="19.3"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.5" upper_limit="1.6"/>
                    <measurement group_id="O8" value="6" lower_limit="2.4" upper_limit="15"/>
                    <measurement group_id="O9" value="1.3" lower_limit="0.7" upper_limit="2.5"/>
                    <measurement group_id="O10" value="8.2" lower_limit="3.6" upper_limit="18.6"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" lower_limit="0.8" upper_limit="8.3"/>
                    <measurement group_id="O2" value="7.1" lower_limit="2.4" upper_limit="20.3"/>
                    <measurement group_id="O3" value="8.3" lower_limit="3.4" upper_limit="20.1"/>
                    <measurement group_id="O4" value="2.4" lower_limit="1.1" upper_limit="5.1"/>
                    <measurement group_id="O5" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O6" value="6.8" lower_limit="2.2" upper_limit="21.1"/>
                    <measurement group_id="O7" value="1" lower_limit="1" upper_limit="1.1"/>
                    <measurement group_id="O8" value="2.3" lower_limit="1.2" upper_limit="4.4"/>
                    <measurement group_id="O9" value="1.4" lower_limit="0.9" upper_limit="2"/>
                    <measurement group_id="O10" value="16.1" lower_limit="5.7" upper_limit="45.4"/>
                    <measurement group_id="O11" value="1.3" lower_limit="1" upper_limit="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" lower_limit="1.1" upper_limit="12.8"/>
                    <measurement group_id="O2" value="6.6" lower_limit="2.5" upper_limit="17.6"/>
                    <measurement group_id="O3" value="6.8" lower_limit="2.8" upper_limit="16.1"/>
                    <measurement group_id="O4" value="2.3" lower_limit="1.2" upper_limit="4.2"/>
                    <measurement group_id="O5" value="0.9" lower_limit="0.8" upper_limit="1"/>
                    <measurement group_id="O6" value="11.7" lower_limit="4.7" upper_limit="29.2"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="3.3" lower_limit="1.4" upper_limit="8"/>
                    <measurement group_id="O9" value="1.3" lower_limit="0.9" upper_limit="1.8"/>
                    <measurement group_id="O10" value="16.4" lower_limit="7" upper_limit="38.3"/>
                    <measurement group_id="O11" value="1.4" lower_limit="1" upper_limit="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="1.1" upper_limit="12.8"/>
                    <measurement group_id="O2" value="5.1" lower_limit="1.9" upper_limit="13.4"/>
                    <measurement group_id="O3" value="6" lower_limit="2.6" upper_limit="14.3"/>
                    <measurement group_id="O4" value="2.2" lower_limit="1.1" upper_limit="4.4"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.6" upper_limit="2.2"/>
                    <measurement group_id="O6" value="10.8" lower_limit="4.2" upper_limit="27.9"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.9" upper_limit="1"/>
                    <measurement group_id="O8" value="3" lower_limit="1.4" upper_limit="6.4"/>
                    <measurement group_id="O9" value="1" lower_limit="0.9" upper_limit="1.2"/>
                    <measurement group_id="O10" value="13.4" lower_limit="5.7" upper_limit="31.6"/>
                    <measurement group_id="O11" value="1.3" lower_limit="1" upper_limit="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" lower_limit="1.1" upper_limit="13.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="1.8" upper_limit="12.6"/>
                    <measurement group_id="O3" value="6.6" lower_limit="2.7" upper_limit="16.1"/>
                    <measurement group_id="O4" value="2.5" lower_limit="1.1" upper_limit="5.5"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.5" upper_limit="4.1"/>
                    <measurement group_id="O6" value="12.3" lower_limit="4.6" upper_limit="32.6"/>
                    <measurement group_id="O7" value="1" lower_limit="0.9" upper_limit="1.1"/>
                    <measurement group_id="O8" value="3.4" lower_limit="1.4" upper_limit="7.9"/>
                    <measurement group_id="O9" value="1.2" lower_limit="1" upper_limit="1.6"/>
                    <measurement group_id="O10" value="13.1" lower_limit="6.1" upper_limit="27.8"/>
                    <measurement group_id="O11" value="1.2" lower_limit="0.9" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" lower_limit="1.3" upper_limit="16.3"/>
                    <measurement group_id="O2" value="4.6" lower_limit="1.8" upper_limit="11.6"/>
                    <measurement group_id="O3" value="5.8" lower_limit="2.5" upper_limit="13.8"/>
                    <measurement group_id="O4" value="2.4" lower_limit="1.2" upper_limit="5"/>
                    <measurement group_id="O5" value="1.5" lower_limit="0.5" upper_limit="4.5"/>
                    <measurement group_id="O6" value="12.8" lower_limit="4.6" upper_limit="35.5"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.9" upper_limit="1.3"/>
                    <measurement group_id="O8" value="3.7" lower_limit="1.6" upper_limit="8.5"/>
                    <measurement group_id="O9" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                    <measurement group_id="O10" value="12.7" lower_limit="6.3" upper_limit="25.5"/>
                    <measurement group_id="O11" value="1.3" lower_limit="1" upper_limit="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2.3" upper_limit="10.8"/>
                    <measurement group_id="O2" value="6.8" lower_limit="2.8" upper_limit="16.4"/>
                    <measurement group_id="O3" value="12" lower_limit="5.5" upper_limit="26.2"/>
                    <measurement group_id="O4" value="3.5" lower_limit="1.1" upper_limit="11.5"/>
                    <measurement group_id="O5" value="1.6" lower_limit="0.5" upper_limit="4.5"/>
                    <measurement group_id="O6" value="18.1" lower_limit="4.4" upper_limit="74.6"/>
                    <measurement group_id="O7" value="1.3" lower_limit="1" upper_limit="1.6"/>
                    <measurement group_id="O8" value="5.7" lower_limit="1.7" upper_limit="19.6"/>
                    <measurement group_id="O9" value="1" lower_limit="0.7" upper_limit="1.5"/>
                    <measurement group_id="O10" value="12.2" lower_limit="5.7" upper_limit="26.3"/>
                    <measurement group_id="O11" value="1" lower_limit="0.9" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" lower_limit="1.4" upper_limit="6.7"/>
                    <measurement group_id="O2" value="4" lower_limit="1.6" upper_limit="10"/>
                    <measurement group_id="O3" value="3.9" lower_limit="1.5" upper_limit="10"/>
                    <measurement group_id="O4" value="1.7" lower_limit="0.7" upper_limit="4.2"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.8" upper_limit="2.6"/>
                    <measurement group_id="O6" value="13.4" lower_limit="3.4" upper_limit="51.9"/>
                    <measurement group_id="O7" value="1.2" lower_limit="0.8" upper_limit="1.8"/>
                    <measurement group_id="O8" value="3.6" lower_limit="0.9" upper_limit="14.9"/>
                    <measurement group_id="O9" value="1.2" lower_limit="0.6" upper_limit="2.3"/>
                    <measurement group_id="O10" value="6.5" lower_limit="3.4" upper_limit="12.2"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.6" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" lower_limit="1" upper_limit="7.4"/>
                    <measurement group_id="O2" value="4.6" lower_limit="2" upper_limit="10.6"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.8" upper_limit="7.5"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.6" upper_limit="5.9"/>
                    <measurement group_id="O5" value="1.3" lower_limit="0.7" upper_limit="2.5"/>
                    <measurement group_id="O6" value="7.7" lower_limit="2.5" upper_limit="23.7"/>
                    <measurement group_id="O7" value="1.4" lower_limit="0.8" upper_limit="2.5"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.6" upper_limit="9.9"/>
                    <measurement group_id="O9" value="1.9" lower_limit="0.9" upper_limit="4.3"/>
                    <measurement group_id="O10" value="6" lower_limit="3.2" upper_limit="11.2"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.7" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgM as Compared to Baseline</title>
        <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMFR of Serum Anti-norovirus GI.1 and GII.4 VLP IgM as Compared to Baseline</title>
          <description>Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgA</title>
        <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgA</title>
          <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="90.0" lower_limit="55.5" upper_limit="99.7"/>
                    <measurement group_id="O4" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O8" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="90.0" lower_limit="55.5" upper_limit="99.7"/>
                    <measurement group_id="O4" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O4" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O2" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O3" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O4" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O2" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O3" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O4" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="11.8" upper_limit="88.2"/>
                    <measurement group_id="O2" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O3" value="37.5" lower_limit="8.5" upper_limit="75.5"/>
                    <measurement group_id="O4" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O3" value="70.0" lower_limit="34.8" upper_limit="93.3"/>
                    <measurement group_id="O4" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O3" value="50.0" lower_limit="18.7" upper_limit="81.3"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O3" value="50.0" lower_limit="18.7" upper_limit="81.3"/>
                    <measurement group_id="O4" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O2" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O3" value="50.0" lower_limit="18.7" upper_limit="81.3"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O4" value="37.5" lower_limit="8.5" upper_limit="75.5"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O2" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O3" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="45.9"/>
                    <measurement group_id="O2" value="42.6" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O3" value="37.5" lower_limit="8.5" upper_limit="75.5"/>
                    <measurement group_id="O4" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgG</title>
        <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgG</title>
          <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O8" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O2" value="85.7" lower_limit="42.1" upper_limit="99.6"/>
                    <measurement group_id="O3" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O4" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="11.8" upper_limit="88.2"/>
                    <measurement group_id="O2" value="85.7" lower_limit="42.1" upper_limit="99.6"/>
                    <measurement group_id="O3" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O4" value="85.7" lower_limit="42.1" upper_limit="99.6"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O2" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O3" value="80.0" lower_limit="44.4" upper_limit="97.5"/>
                    <measurement group_id="O4" value="28.6" lower_limit="3.7" upper_limit="871.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O2" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O3" value="70.0" lower_limit="34.8" upper_limit="93.3"/>
                    <measurement group_id="O4" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O2" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O3" value="70.0" lower_limit="34.8" upper_limit="93.3"/>
                    <measurement group_id="O4" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="44.4" lower_limit="13.7" upper_limit="878.8"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="70.0" lower_limit="34.8" upper_limit="93.3"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="7.5" upper_limit="70.1"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O4" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O3" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O4" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O2" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O3" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="3.5" upper_limit="65.1"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="4.3" upper_limit="77.7"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="50.0" lower_limit="15.7" upper_limit="584.3"/>
                    <measurement group_id="O4" value="28.6" lower_limit="3.7" upper_limit="71.0"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O9" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O10" value="85.7" lower_limit="42.1" upper_limit="99.6"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgM</title>
        <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Seroresponse for Serum Anti-norovirus GI.1 and GII.4 VLP IgM</title>
          <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>Data was not collected because serum specimens were not tested for specific IgM antibodies to Norovirus GI.1 and GII.4 VLPs as per the change in planned analysis, because this measurement was not informative in a previous study LV01-103 (NCT00973284).</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMT of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig Enzyme-Linked Immunosorbent Assay (ELISA)</title>
        <description>GMTs were assessed for Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: predose 1, 7, 21, 28 days PD1, 7 and 28 days PD2; II run: predose 1, 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMT of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig Enzyme-Linked Immunosorbent Assay (ELISA)</title>
          <description>GMTs were assessed for Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3763" lower_limit="894" upper_limit="15838"/>
                    <measurement group_id="O2" value="2348" lower_limit="599" upper_limit="9198"/>
                    <measurement group_id="O3" value="2560" lower_limit="950" upper_limit="6901"/>
                    <measurement group_id="O4" value="2153" lower_limit="447" upper_limit="10366"/>
                    <measurement group_id="O5" value="1396" lower_limit="162" upper_limit="12052"/>
                    <measurement group_id="O6" value="1810" lower_limit="486" upper_limit="6737"/>
                    <measurement group_id="O7" value="2744" lower_limit="806" upper_limit="9337"/>
                    <measurement group_id="O8" value="6451" lower_limit="2020" upper_limit="20603"/>
                    <measurement group_id="O9" value="2763" lower_limit="668" upper_limit="21197"/>
                    <measurement group_id="O10" value="1280" lower_limit="320" upper_limit="5115"/>
                    <measurement group_id="O11" value="861" lower_limit="147" upper_limit="5054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163840" lower_limit="77123" upper_limit="348063"/>
                    <measurement group_id="O2" value="231705" lower_limit="135499" upper_limit="396217"/>
                    <measurement group_id="O3" value="351199" lower_limit="159240" upper_limit="774559"/>
                    <measurement group_id="O4" value="220512" lower_limit="57489" upper_limit="831259"/>
                    <measurement group_id="O5" value="1185" lower_limit="179" upper_limit="7861"/>
                    <measurement group_id="O6" value="150242" lower_limit="52704" upper_limit="428288"/>
                    <measurement group_id="O7" value="2229" lower_limit="596" upper_limit="8327"/>
                    <measurement group_id="O8" value="151695" lower_limit="57115" upper_limit="402894"/>
                    <measurement group_id="O9" value="3763" lower_limit="668" upper_limit="21197"/>
                    <measurement group_id="O10" value="126338" lower_limit="39749" upper_limit="401554"/>
                    <measurement group_id="O11" value="861" lower_limit="153" upper_limit="4860"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="260080" lower_limit="122425" upper_limit="552516"/>
                    <measurement group_id="O2" value="194840" lower_limit="92705" upper_limit="409496"/>
                    <measurement group_id="O3" value="285262" lower_limit="127800" upper_limit="636731"/>
                    <measurement group_id="O4" value="212474" lower_limit="93970" upper_limit="480425"/>
                    <measurement group_id="O5" value="1185" lower_limit="193" upper_limit="7282"/>
                    <measurement group_id="O6" value="212474" lower_limit="114914" upper_limit="392862"/>
                    <measurement group_id="O7" value="2389" lower_limit="658" upper_limit="8676"/>
                    <measurement group_id="O8" value="115852" lower_limit="51050" upper_limit="262916"/>
                    <measurement group_id="O9" value="7241" lower_limit="2719" upper_limit="19283"/>
                    <measurement group_id="O10" value="137772" lower_limit="58166" upper_limit="326329"/>
                    <measurement group_id="O11" value="861" lower_limit="207" upper_limit="3587"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222952" lower_limit="109569" upper_limit="453664"/>
                    <measurement group_id="O2" value="126338" lower_limit="59394" upper_limit="268734"/>
                    <measurement group_id="O3" value="216188" lower_limit="102476" upper_limit="456081"/>
                    <measurement group_id="O4" value="194840" lower_limit="106949" upper_limit="354959"/>
                    <measurement group_id="O5" value="1280" lower_limit="219" upper_limit="7493"/>
                    <measurement group_id="O6" value="212474" lower_limit="106756" upper_limit="422883"/>
                    <measurement group_id="O7" value="2389" lower_limit="658" upper_limit="8676"/>
                    <measurement group_id="O8" value="120401" lower_limit="56380" upper_limit="257117"/>
                    <measurement group_id="O9" value="3763" lower_limit="696" upper_limit="20334"/>
                    <measurement group_id="O10" value="106230" lower_limit="42084" upper_limit="268187"/>
                    <measurement group_id="O11" value="707" lower_limit="122" upper_limit="4078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176957" lower_limit="85545" upper_limit="366049"/>
                    <measurement group_id="O2" value="163840" lower_limit="86301" upper_limit="311047"/>
                    <measurement group_id="O3" value="266159" lower_limit="143088" upper_limit="495085"/>
                    <measurement group_id="O4" value="212474" lower_limit="124953" upper_limit="361298"/>
                    <measurement group_id="O5" value="1974" lower_limit="396" upper_limit="9852"/>
                    <measurement group_id="O6" value="231705" lower_limit="169986" upper_limit="315832"/>
                    <measurement group_id="O7" value="2229" lower_limit="584" upper_limit="8500"/>
                    <measurement group_id="O8" value="176957" lower_limit="116676" upper_limit="268383"/>
                    <measurement group_id="O9" value="4389" lower_limit="872" upper_limit="22081"/>
                    <measurement group_id="O10" value="126338" lower_limit="68328" upper_limit="233597"/>
                    <measurement group_id="O11" value="861" lower_limit="207" upper_limit="3587"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206425" lower_limit="102014" upper_limit="417702"/>
                    <measurement group_id="O2" value="148394" lower_limit="83353" upper_limit="264185"/>
                    <measurement group_id="O3" value="176957" lower_limit="81595" upper_limit="383771"/>
                    <measurement group_id="O4" value="150242" lower_limit="92634" upper_limit="243676"/>
                    <measurement group_id="O5" value="1974" lower_limit="352" upper_limit="11056"/>
                    <measurement group_id="O6" value="300484" lower_limit="156475" upper_limit="577028"/>
                    <measurement group_id="O7" value="2079" lower_limit="532" upper_limit="8134"/>
                    <measurement group_id="O8" value="176957" lower_limit="128475" upper_limit="243735"/>
                    <measurement group_id="O9" value="5120" lower_limit="1388" upper_limit="18883"/>
                    <measurement group_id="O10" value="89334" lower_limit="61622" upper_limit="129510"/>
                    <measurement group_id="O11" value="861" lower_limit="180" upper_limit="4116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4389" lower_limit="978" upper_limit="19405"/>
                    <measurement group_id="O2" value="3121" lower_limit="657" upper_limit="14817"/>
                    <measurement group_id="O3" value="3484" lower_limit="870" upper_limit="13946"/>
                    <measurement group_id="O4" value="1974" lower_limit="408" upper_limit="9540"/>
                    <measurement group_id="O5" value="3121" lower_limit="415" upper_limit="23466"/>
                    <measurement group_id="O6" value="2560" lower_limit="803" upper_limit="8158"/>
                    <measurement group_id="O7" value="2941" lower_limit="804" upper_limit="10760"/>
                    <measurement group_id="O8" value="4389" lower_limit="156" upper_limit="12222"/>
                    <measurement group_id="O9" value="2560" lower_limit="567" upper_limit="11554"/>
                    <measurement group_id="O10" value="587" lower_limit="155" upper_limit="2219"/>
                    <measurement group_id="O11" value="390" lower_limit="82" upper_limit="1852"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="260080" lower_limit="112007" upper_limit="603906"/>
                    <measurement group_id="O2" value="243465" lower_limit="117694" upper_limit="503640"/>
                    <measurement group_id="O3" value="222952" lower_limit="91740" upper_limit="541832"/>
                    <measurement group_id="O4" value="212474" lower_limit="124953" upper_limit="361298"/>
                    <measurement group_id="O5" value="3446" lower_limit="506" upper_limit="23456"/>
                    <measurement group_id="O6" value="357338" lower_limit="246486" upper_limit="518042"/>
                    <measurement group_id="O7" value="2744" lower_limit="696" upper_limit="10819"/>
                    <measurement group_id="O8" value="140451" lower_limit="98461" upper_limit="200348"/>
                    <measurement group_id="O9" value="2195" lower_limit="392" upper_limit="12279"/>
                    <measurement group_id="O10" value="89334" lower_limit="61622" upper_limit="129510"/>
                    <measurement group_id="O11" value="353" lower_limit="53" upper_limit="2369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97420" lower_limit="41130" upper_limit="230749"/>
                    <measurement group_id="O2" value="121733" lower_limit="53847" upper_limit="275205"/>
                    <measurement group_id="O3" value="95562" lower_limit="43402" upper_limit="210408"/>
                    <measurement group_id="O4" value="126338" lower_limit="93602" upper_limit="170523"/>
                    <measurement group_id="O5" value="3121" lower_limit="478" upper_limit="20386"/>
                    <measurement group_id="O6" value="150242" lower_limit="103635" upper_limit="217810"/>
                    <measurement group_id="O7" value="2941" lower_limit="756" upper_limit="11445"/>
                    <measurement group_id="O8" value="81920" lower_limit="56204" upper_limit="119401"/>
                    <measurement group_id="O9" value="2370" lower_limit="409" upper_limit="13721"/>
                    <measurement group_id="O10" value="31584" lower_limit="20522" upper_limit="48609"/>
                    <measurement group_id="O11" value="390" lower_limit="75" upper_limit="2018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145965" lower_limit="62364" upper_limit="341636"/>
                    <measurement group_id="O2" value="67202" lower_limit="25756" upper_limit="175341"/>
                    <measurement group_id="O3" value="63169" lower_limit="21663" upper_limit="184198"/>
                    <measurement group_id="O4" value="81920" lower_limit="48537" upper_limit="138264"/>
                    <measurement group_id="O5" value="2153" lower_limit="409" upper_limit="11331"/>
                    <measurement group_id="O6" value="75121" lower_limit="51817" upper_limit="108905"/>
                    <measurement group_id="O7" value="2941" lower_limit="699" upper_limit="12376"/>
                    <measurement group_id="O8" value="47781" lower_limit="30650" upper_limit="74487"/>
                    <measurement group_id="O9" value="3484" lower_limit="560" upper_limit="21684"/>
                    <measurement group_id="O10" value="18549" lower_limit="10419" upper_limit="33023"/>
                    <measurement group_id="O11" value="353" lower_limit="64" upper_limit="1960"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run: Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11945" lower_limit="3089" upper_limit="46196"/>
                    <measurement group_id="O2" value="3948" lower_limit="1103" upper_limit="14126"/>
                    <measurement group_id="O3" value="1470" lower_limit="287" upper_limit="7526"/>
                    <measurement group_id="O4" value="28963" lower_limit="5792" upper_limit="144824"/>
                    <measurement group_id="O5" value="5583" lower_limit="1425" upper_limit="21877"/>
                    <measurement group_id="O6" value="4695" lower_limit="804" upper_limit="27403"/>
                    <measurement group_id="O7" value="2229" lower_limit="408" upper_limit="12181"/>
                    <measurement group_id="O8" value="9481" lower_limit="1706" upper_limit="52683"/>
                    <measurement group_id="O9" value="8127" lower_limit="1540" upper_limit="42902"/>
                    <measurement group_id="O10" value="6089" lower_limit="2015" upper_limit="18402"/>
                    <measurement group_id="O11" value="9275" lower_limit="2069" upper_limit="41572"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55738" lower_limit="32476" upper_limit="95661"/>
                    <measurement group_id="O2" value="53119" lower_limit="23492" upper_limit="120106"/>
                    <measurement group_id="O3" value="71316" lower_limit="35649" upper_limit="142667"/>
                    <measurement group_id="O4" value="593575" lower_limit="250592" upper_limit="1405995"/>
                    <measurement group_id="O5" value="4740" lower_limit="1381" upper_limit="16278"/>
                    <measurement group_id="O6" value="115852" lower_limit="45745" upper_limit="293407"/>
                    <measurement group_id="O7" value="1940" lower_limit="377" upper_limit="9997"/>
                    <measurement group_id="O8" value="88478" lower_limit="42773" upper_limit="183024"/>
                    <measurement group_id="O9" value="6451" lower_limit="1429" upper_limit="29113"/>
                    <measurement group_id="O10" value="300484" lower_limit="110464" upper_limit="817377"/>
                    <measurement group_id="O11" value="7608" lower_limit="1665" upper_limit="34773"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70225" lower_limit="39229" upper_limit="125714"/>
                    <measurement group_id="O2" value="44667" lower_limit="20355" upper_limit="98017"/>
                    <measurement group_id="O3" value="50428" lower_limit="24962" upper_limit="101872"/>
                    <measurement group_id="O4" value="505352" lower_limit="297190" upper_limit="859315"/>
                    <measurement group_id="O5" value="5120" lower_limit="1603" upper_limit="16352"/>
                    <measurement group_id="O6" value="163840" lower_limit="81963" upper_limit="327507"/>
                    <measurement group_id="O7" value="1810" lower_limit="329" upper_limit="9966"/>
                    <measurement group_id="O8" value="126338" lower_limit="55875" upper_limit="285662"/>
                    <measurement group_id="O9" value="9390" lower_limit="1854" upper_limit="47567"/>
                    <measurement group_id="O10" value="212474" lower_limit="114914" upper_limit="392862"/>
                    <measurement group_id="O11" value="8400" lower_limit="1694" upper_limit="41653"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="9"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70225" lower_limit="33407" upper_limit="147623"/>
                    <measurement group_id="O2" value="40960" lower_limit="19180" upper_limit="87472"/>
                    <measurement group_id="O3" value="38217" lower_limit="17951" upper_limit="81361"/>
                    <measurement group_id="O4" value="275545" lower_limit="151249" upper_limit="501988"/>
                    <measurement group_id="O5" value="6451" lower_limit="2151" upper_limit="19348"/>
                    <measurement group_id="O6" value="150242" lower_limit="84602" upper_limit="266810"/>
                    <measurement group_id="O7" value="2079" lower_limit="426" upper_limit="10158"/>
                    <measurement group_id="O8" value="111476" lower_limit="52201" upper_limit="238058"/>
                    <measurement group_id="O9" value="7525" lower_limit="1588" upper_limit="35664"/>
                    <measurement group_id="O10" value="126338" lower_limit="74298" upper_limit="214829"/>
                    <measurement group_id="O11" value="7608" lower_limit="1665" upper_limit="34773"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75848" lower_limit="40737" upper_limit="141221"/>
                    <measurement group_id="O2" value="60866" lower_limit="36756" upper_limit="100792"/>
                    <measurement group_id="O3" value="43900" lower_limit="24247" upper_limit="79483"/>
                    <measurement group_id="O4" value="300484" lower_limit="185267" upper_limit="487353"/>
                    <measurement group_id="O5" value="10240" lower_limit="3502" upper_limit="29943"/>
                    <measurement group_id="O6" value="163840" lower_limit="88181" upper_limit="304413"/>
                    <measurement group_id="O7" value="1810" lower_limit="329" upper_limit="9966"/>
                    <measurement group_id="O8" value="130040" lower_limit="67714" upper_limit="249731"/>
                    <measurement group_id="O9" value="8127" lower_limit="1573" upper_limit="41991"/>
                    <measurement group_id="O10" value="178669" lower_limit="100609" upper_limit="317292"/>
                    <measurement group_id="O11" value="10240" lower_limit="2130" upper_limit="49233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75848" lower_limit="34973" upper_limit="164493"/>
                    <measurement group_id="O2" value="60866" lower_limit="36756" upper_limit="100792"/>
                    <measurement group_id="O3" value="47781" lower_limit="25186" upper_limit="90647"/>
                    <measurement group_id="O4" value="212474" lower_limit="106756" upper_limit="422883"/>
                    <measurement group_id="O5" value="11167" lower_limit="3442" upper_limit="36230"/>
                    <measurement group_id="O6" value="126338" lower_limit="68328" upper_limit="233597"/>
                    <measurement group_id="O7" value="1810" lower_limit="363" upper_limit="9026"/>
                    <measurement group_id="O8" value="103213" lower_limit="46414" upper_limit="229521"/>
                    <measurement group_id="O9" value="6967" lower_limit="1405" upper_limit="34539"/>
                    <measurement group_id="O10" value="115852" lower_limit="57957" upper_limit="231582"/>
                    <measurement group_id="O11" value="10240" lower_limit="2330" upper_limit="45004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:Pre-Dose 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13934" lower_limit="3481" upper_limit="55783"/>
                    <measurement group_id="O2" value="10240" lower_limit="2841" upper_limit="36907"/>
                    <measurement group_id="O3" value="4389" lower_limit="1026" upper_limit="18781"/>
                    <measurement group_id="O4" value="18780" lower_limit="3498" upper_limit="100825"/>
                    <measurement group_id="O5" value="4200" lower_limit="968" upper_limit="18216"/>
                    <measurement group_id="O6" value="3948" lower_limit="544" upper_limit="28648"/>
                    <measurement group_id="O7" value="2560" lower_limit="606" upper_limit="10815"/>
                    <measurement group_id="O8" value="7525" lower_limit="1257" upper_limit="45038"/>
                    <measurement group_id="O9" value="6967" lower_limit="1540" upper_limit="31526"/>
                    <measurement group_id="O10" value="5120" lower_limit="2022" upper_limit="12967"/>
                    <measurement group_id="O11" value="5653" lower_limit="1106" upper_limit="28892"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88478" lower_limit="44992" upper_limit="173997"/>
                    <measurement group_id="O2" value="90447" lower_limit="38184" upper_limit="214241"/>
                    <measurement group_id="O3" value="103213" lower_limit="65064" upper_limit="163729"/>
                    <measurement group_id="O4" value="126338" lower_limit="63477" upper_limit="251448"/>
                    <measurement group_id="O5" value="8400" lower_limit="1240" upper_limit="56896"/>
                    <measurement group_id="O6" value="150242" lower_limit="78238" upper_limit="288514"/>
                    <measurement group_id="O7" value="2560" lower_limit="727" upper_limit="9014"/>
                    <measurement group_id="O8" value="65020" lower_limit="32132" upper_limit="131568"/>
                    <measurement group_id="O9" value="6967" lower_limit="1577" upper_limit="30788"/>
                    <measurement group_id="O10" value="115852" lower_limit="62354" upper_limit="215253"/>
                    <measurement group_id="O11" value="6241" lower_limit="1439" upper_limit="27068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81920" lower_limit="34112" upper_limit="196732"/>
                    <measurement group_id="O2" value="49931" lower_limit="24467" upper_limit="101894"/>
                    <measurement group_id="O3" value="27869" lower_limit="15260" upper_limit="50896"/>
                    <measurement group_id="O4" value="63169" lower_limit="34164" upper_limit="116798"/>
                    <measurement group_id="O5" value="6241" lower_limit="1158" upper_limit="33639"/>
                    <measurement group_id="O6" value="150242" lower_limit="48269" upper_limit="467639"/>
                    <measurement group_id="O7" value="2744" lower_limit="740" upper_limit="10177"/>
                    <measurement group_id="O8" value="35113" lower_limit="14643" upper_limit="84196"/>
                    <measurement group_id="O9" value="8778" lower_limit="2002" upper_limit="38482"/>
                    <measurement group_id="O10" value="48710" lower_limit="23176" upper_limit="102374"/>
                    <measurement group_id="O11" value="5653" lower_limit="1321" upper_limit="24190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45976" lower_limit="13134" upper_limit="160938"/>
                    <measurement group_id="O2" value="49931" lower_limit="19137" upper_limit="130278"/>
                    <measurement group_id="O3" value="20480" lower_limit="11977" upper_limit="35021"/>
                    <measurement group_id="O4" value="67202" lower_limit="25756" upper_limit="175341"/>
                    <measurement group_id="O5" value="3948" lower_limit="957" upper_limit="16290"/>
                    <measurement group_id="O6" value="57926" lower_limit="33875" upper_limit="99054"/>
                    <measurement group_id="O7" value="3378" lower_limit="690" upper_limit="16544"/>
                    <measurement group_id="O8" value="27869" lower_limit="11467" upper_limit="67729"/>
                    <measurement group_id="O9" value="12902" lower_limit="3151" upper_limit="52826"/>
                    <measurement group_id="O10" value="37098" lower_limit="17025" upper_limit="80838"/>
                    <measurement group_id="O11" value="5653" lower_limit="1321" upper_limit="24190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMFR of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA as Compared to Baseline</title>
        <description>GMFRs in GMTs of Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>GMFR of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA as Compared to Baseline</title>
          <description>GMFRs in GMTs of Anti-norovirus GI.1 and GII.4 VLP by Pan-Ig ELISA. A pan ELISA assay captured IgG, IgA and IgM combined. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>fold rise</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.5" lower_limit="9.9" upper_limit="192.4"/>
                    <measurement group_id="O2" value="98.7" lower_limit="21.7" upper_limit="449.2"/>
                    <measurement group_id="O3" value="137.2" lower_limit="50.3" upper_limit="374.4"/>
                    <measurement group_id="O4" value="128" lower_limit="61.1" upper_limit="268.3"/>
                    <measurement group_id="O5" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O6" value="83" lower_limit="9.7" upper_limit="708.7"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1"/>
                    <measurement group_id="O8" value="23.5" lower_limit="5.5" upper_limit="101.4"/>
                    <measurement group_id="O9" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O10" value="98.7" lower_limit="28.7" upper_limit="339.9"/>
                    <measurement group_id="O11" value="1" lower_limit="0.7" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.1" lower_limit="15.9" upper_limit="300.6"/>
                    <measurement group_id="O2" value="83" lower_limit="17.7" upper_limit="389.8"/>
                    <measurement group_id="O3" value="111.4" lower_limit="51.7" upper_limit="240.2"/>
                    <measurement group_id="O4" value="98.7" lower_limit="41.2" upper_limit="236.2"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.8" upper_limit="1.6"/>
                    <measurement group_id="O6" value="117.4" lower_limit="23.2" upper_limit="594.6"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.7" upper_limit="1.1"/>
                    <measurement group_id="O8" value="20.7" lower_limit="4.2" upper_limit="103.6"/>
                    <measurement group_id="O9" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O10" value="107.6" lower_limit="23.8" upper_limit="487"/>
                    <measurement group_id="O11" value="1" lower_limit="0.6" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.3" lower_limit="12.4" upper_limit="283"/>
                    <measurement group_id="O2" value="53.8" lower_limit="11.5" upper_limit="251.3"/>
                    <measurement group_id="O3" value="84.4" lower_limit="49.6" upper_limit="143.9"/>
                    <measurement group_id="O4" value="90.5" lower_limit="31" upper_limit="264.7"/>
                    <measurement group_id="O5" value="1.2" lower_limit="0.8" upper_limit="1.8"/>
                    <measurement group_id="O6" value="117.4" lower_limit="19.1" upper_limit="722.8"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.7" upper_limit="1.1"/>
                    <measurement group_id="O8" value="18.7" lower_limit="5.7" upper_limit="61"/>
                    <measurement group_id="O9" value="1" lower_limit="0.8" upper_limit="1.3"/>
                    <measurement group_id="O10" value="83" lower_limit="18.2" upper_limit="377.8"/>
                    <measurement group_id="O11" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="8.9" upper_limit="248.9"/>
                    <measurement group_id="O2" value="78" lower_limit="15.1" upper_limit="403.5"/>
                    <measurement group_id="O3" value="104" lower_limit="58.5" upper_limit="184.8"/>
                    <measurement group_id="O4" value="98.7" lower_limit="31.1" upper_limit="313.7"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.6" upper_limit="3.2"/>
                    <measurement group_id="O6" value="128" lower_limit="29" upper_limit="565.4"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1"/>
                    <measurement group_id="O8" value="27.4" lower_limit="8.9" upper_limit="84.3"/>
                    <measurement group_id="O9" value="1.2" lower_limit="0.9" upper_limit="1.5"/>
                    <measurement group_id="O10" value="98.7" lower_limit="28.7" upper_limit="339.9"/>
                    <measurement group_id="O11" value="1" lower_limit="0.6" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.9" lower_limit="10.2" upper_limit="294.4"/>
                    <measurement group_id="O2" value="70.7" lower_limit="16.5" upper_limit="302.4"/>
                    <measurement group_id="O3" value="64" lower_limit="37.6" upper_limit="109"/>
                    <measurement group_id="O4" value="69.8" lower_limit="20.7" upper_limit="235.7"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.6" upper_limit="3.2"/>
                    <measurement group_id="O6" value="166" lower_limit="35.3" upper_limit="779.6"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.5" upper_limit="1.1"/>
                    <measurement group_id="O8" value="27.4" lower_limit="9.9" upper_limit="76.4"/>
                    <measurement group_id="O9" value="1.4" lower_limit="0.7" upper_limit="2.5"/>
                    <measurement group_id="O10" value="69.8" lower_limit="19.9" upper_limit="245"/>
                    <measurement group_id="O11" value="1" lower_limit="0.7" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.3" lower_limit="13" upper_limit="270.2"/>
                    <measurement group_id="O2" value="78" lower_limit="16.4" upper_limit="370.4"/>
                    <measurement group_id="O3" value="64" lower_limit="31.6" upper_limit="129.5"/>
                    <measurement group_id="O4" value="107.6" lower_limit="34.1" upper_limit="339.4"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.6" upper_limit="2"/>
                    <measurement group_id="O6" value="139.6" lower_limit="46.8" upper_limit="416.2"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.6" upper_limit="1.3"/>
                    <measurement group_id="O8" value="32" lower_limit="12.2" upper_limit="83.6"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.7" upper_limit="1.1"/>
                    <measurement group_id="O10" value="152.2" lower_limit="41.3" upper_limit="561.3"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.6" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.4" lower_limit="4.3" upper_limit="70.8"/>
                    <measurement group_id="O2" value="39" lower_limit="7.9" upper_limit="193.4"/>
                    <measurement group_id="O3" value="27.4" lower_limit="11.9" upper_limit="63.1"/>
                    <measurement group_id="O4" value="64" lower_limit="15" upper_limit="273.6"/>
                    <measurement group_id="O5" value="1" lower_limit="0.7" upper_limit="1.4"/>
                    <measurement group_id="O6" value="58.7" lower_limit="21.6" upper_limit="159.6"/>
                    <measurement group_id="O7" value="1" lower_limit="0.7" upper_limit="1.5"/>
                    <measurement group_id="O8" value="18.7" lower_limit="8.5" upper_limit="41.1"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.7" upper_limit="1.3"/>
                    <measurement group_id="O10" value="53.8" lower_limit="15.7" upper_limit="184"/>
                    <measurement group_id="O11" value="1" lower_limit="0.7" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.4" lower_limit="2.1" upper_limit="311.2"/>
                    <measurement group_id="O2" value="21.5" lower_limit="4.7" upper_limit="98.4"/>
                    <measurement group_id="O3" value="19" lower_limit="8.5" upper_limit="42.5"/>
                    <measurement group_id="O4" value="58" lower_limit="16.6" upper_limit="202.6"/>
                    <measurement group_id="O5" value="1" lower_limit="0.6" upper_limit="1.7"/>
                    <measurement group_id="O6" value="29.3" lower_limit="10.8" upper_limit="79.8"/>
                    <measurement group_id="O7" value="1" lower_limit="0.7" upper_limit="1.5"/>
                    <measurement group_id="O8" value="10.9" lower_limit="3.7" upper_limit="31.7"/>
                    <measurement group_id="O9" value="1.4" lower_limit="0.7" upper_limit="2.5"/>
                    <measurement group_id="O10" value="43.1" lower_limit="19.7" upper_limit="97.4"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.6" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" lower_limit="1.5" upper_limit="14.3"/>
                    <measurement group_id="O2" value="13.5" lower_limit="3" upper_limit="60.9"/>
                    <measurement group_id="O3" value="48.5" lower_limit="7.9" upper_limit="297.4"/>
                    <measurement group_id="O4" value="19.5" lower_limit="1.8" upper_limit="213"/>
                    <measurement group_id="O5" value="1" lower_limit="NA" upper_limit="NA">Confidence interval could not be calculated because there was no variance in the observed data.</measurement>
                    <measurement group_id="O6" value="24.7" lower_limit="4.7" upper_limit="130.6"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.6" upper_limit="1.2"/>
                    <measurement group_id="O8" value="9.3" lower_limit="2.2" upper_limit="39.9"/>
                    <measurement group_id="O9" value="0.8" lower_limit="0.6" upper_limit="1"/>
                    <measurement group_id="O10" value="49.4" lower_limit="9.6" upper_limit="253.7"/>
                    <measurement group_id="O11" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" lower_limit="1.5" upper_limit="23.5"/>
                    <measurement group_id="O2" value="11.3" lower_limit="3.6" upper_limit="36.1"/>
                    <measurement group_id="O3" value="34.3" lower_limit="7.3" upper_limit="160.1"/>
                    <measurement group_id="O4" value="17.4" lower_limit="3.2" upper_limit="96.4"/>
                    <measurement group_id="O5" value="1.1" lower_limit="0.8" upper_limit="1.6"/>
                    <measurement group_id="O6" value="34.9" lower_limit="7.1" upper_limit="171.6"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                    <measurement group_id="O8" value="19" lower_limit="5.4" upper_limit="67.6"/>
                    <measurement group_id="O9" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                    <measurement group_id="O10" value="34.9" lower_limit="7.5" upper_limit="131.4"/>
                    <measurement group_id="O11" value="0.9" lower_limit="0.6" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" lower_limit="1.5" upper_limit="22.3"/>
                    <measurement group_id="O2" value="10.4" lower_limit="3.6" upper_limit="30.3"/>
                    <measurement group_id="O3" value="26" lower_limit="5.1" upper_limit="131.4"/>
                    <measurement group_id="O4" value="9.5" lower_limit="1.8" upper_limit="50.1"/>
                    <measurement group_id="O5" value="1.4" lower_limit="0.8" upper_limit="2.6"/>
                    <measurement group_id="O6" value="32" lower_limit="7.7" upper_limit="132.3"/>
                    <measurement group_id="O7" value="0.9" lower_limit="0.7" upper_limit="1.2"/>
                    <measurement group_id="O8" value="11.8" lower_limit="3" upper_limit="45.9"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.8" upper_limit="1.1"/>
                    <measurement group_id="O10" value="20.7" lower_limit="5.2" upper_limit="82.7"/>
                    <measurement group_id="O11" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="2" upper_limit="20.3"/>
                    <measurement group_id="O2" value="10.8" lower_limit="2.9" upper_limit="40.6"/>
                    <measurement group_id="O3" value="29.9" lower_limit="6.1" upper_limit="146.9"/>
                    <measurement group_id="O4" value="10.4" lower_limit="2.1" upper_limit="50.2"/>
                    <measurement group_id="O5" value="1.8" lower_limit="0.5" upper_limit="6.2"/>
                    <measurement group_id="O6" value="34.9" lower_limit="6.3" upper_limit="192.7"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                    <measurement group_id="O8" value="13.7" lower_limit="3.1" upper_limit="60.1"/>
                    <measurement group_id="O9" value="1" lower_limit="0.8" upper_limit="1.3"/>
                    <measurement group_id="O10" value="29.3" lower_limit="8.4" upper_limit="103"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.7" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="1.7" upper_limit="24.1"/>
                    <measurement group_id="O2" value="10.8" lower_limit="3.4" upper_limit="34.4"/>
                    <measurement group_id="O3" value="21.8" lower_limit="6.6" upper_limit="71.9"/>
                    <measurement group_id="O4" value="7.3" lower_limit="1.5" upper_limit="35"/>
                    <measurement group_id="O5" value="2" lower_limit="0.5" upper_limit="8.3"/>
                    <measurement group_id="O6" value="26.9" lower_limit="5.4" upper_limit="133.6"/>
                    <measurement group_id="O7" value="0.8" lower_limit="0.6" upper_limit="1.1"/>
                    <measurement group_id="O8" value="10.9" lower_limit="2.5" upper_limit="48.1"/>
                    <measurement group_id="O9" value="0.9" lower_limit="0.7" upper_limit="1.1"/>
                    <measurement group_id="O10" value="19" lower_limit="5.4" upper_limit="67.6"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.7" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="1.6" upper_limit="24.7"/>
                    <measurement group_id="O2" value="8.8" lower_limit="2.5" upper_limit="30.9"/>
                    <measurement group_id="O3" value="23.5" lower_limit="6.5" upper_limit="84.6"/>
                    <measurement group_id="O4" value="6.7" lower_limit="1.5" upper_limit="29.5"/>
                    <measurement group_id="O5" value="2" lower_limit="0.5" upper_limit="8.4"/>
                    <measurement group_id="O6" value="38.1" lower_limit="6" upper_limit="242.5"/>
                    <measurement group_id="O7" value="1" lower_limit="0.8" upper_limit="1.3"/>
                    <measurement group_id="O8" value="8.6" lower_limit="1.9" upper_limit="40.3"/>
                    <measurement group_id="O9" value="1" lower_limit="0.8" upper_limit="1.3"/>
                    <measurement group_id="O10" value="22.6" lower_limit="8.5" upper_limit="60.3"/>
                    <measurement group_id="O11" value="1.1" lower_limit="0.9" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="1.5" upper_limit="9"/>
                    <measurement group_id="O2" value="4.9" lower_limit="1.4" upper_limit="17.3"/>
                    <measurement group_id="O3" value="6.3" lower_limit="1.9" upper_limit="21.5"/>
                    <measurement group_id="O4" value="3.4" lower_limit="0.8" upper_limit="13.3"/>
                    <measurement group_id="O5" value="1.5" lower_limit="0.5" upper_limit="4.2"/>
                    <measurement group_id="O6" value="38.1" lower_limit="7" upper_limit="206.1"/>
                    <measurement group_id="O7" value="1.1" lower_limit="0.7" upper_limit="1.7"/>
                    <measurement group_id="O8" value="4.7" lower_limit="0.9" upper_limit="23"/>
                    <measurement group_id="O9" value="1.3" lower_limit="0.5" upper_limit="3.4"/>
                    <measurement group_id="O10" value="9.5" lower_limit="3.8" upper_limit="23.8"/>
                    <measurement group_id="O11" value="1" lower_limit="0.7" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0.7" upper_limit="23.8"/>
                    <measurement group_id="O2" value="4.9" lower_limit="1.2" upper_limit="19.2"/>
                    <measurement group_id="O3" value="3.4" lower_limit="0.8" upper_limit="13.3"/>
                    <measurement group_id="O4" value="3.3" lower_limit="0.6" upper_limit="17"/>
                    <measurement group_id="O5" value="1.2" lower_limit="0.5" upper_limit="2.7"/>
                    <measurement group_id="O6" value="14.7" lower_limit="2.2" upper_limit="100.1"/>
                    <measurement group_id="O7" value="1.3" lower_limit="0.6" upper_limit="2.8"/>
                    <measurement group_id="O8" value="3.7" lower_limit="0.9" upper_limit="16.1"/>
                    <measurement group_id="O9" value="1.9" lower_limit="0.8" upper_limit="4.4"/>
                    <measurement group_id="O10" value="8.8" lower_limit="4.1" upper_limit="19.2"/>
                    <measurement group_id="O11" value="1" lower_limit="0.7" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Seroresponse (4-Fold Rise) of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA</title>
        <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
        <time_frame>I run: 7, 21, 28 days PD1, 7 and 28 days PD2; II run: 28, 152 and 365 days PD2 (up to Day 393)</time_frame>
        <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O2">
            <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O3">
            <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O4">
            <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
            <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O5">
            <title>Cohort A1-A4: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O6">
            <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O7">
            <title>Cohort B: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
          </group>
          <group group_id="O8">
            <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O9">
            <title>Cohort C: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
          </group>
          <group group_id="O10">
            <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
            <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
          <group group_id="O11">
            <title>Cohort D: Placebo</title>
            <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Seroresponse (4-Fold Rise) of Anti-norovirus GI.1 and GII.4 VLP IgA, IgG, and IgM Combined Using Pan-Ig ELISA</title>
          <description>Seroresponse was defined as a 4-fold increase in antibody titer compared to pre-immunization titers. Run I was defined as the initial analysis performed once Day 56 post dose data was available. Run II was defined as final analysis performed after all later time points were achieved.</description>
          <population>PP population where baseline and specified post-baseline assessment were available. PP population included all participants who received both doses of study product and with no protocol deviations likely to affect the immunogenicity assessment.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
                <count group_id="O6" value="8"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="9"/>
                <count group_id="O9" value="9"/>
                <count group_id="O10" value="8"/>
                <count group_id="O11" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI.1: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="25.0" lower_limit="3.2" upper_limit="65.1"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI.1: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="22.3" upper_limit="95.7"/>
                    <measurement group_id="O2" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O2" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O3" value="80.0" lower_limit="44.4" upper_limit="97.5"/>
                    <measurement group_id="O4" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:21 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="8"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="80.0" lower_limit="44.4" upper_limit="97.5"/>
                    <measurement group_id="O4" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="80.0" lower_limit="44.4" upper_limit="97.5"/>
                    <measurement group_id="O4" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:7 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O2" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O3" value="80.0" lower_limit="44.4" upper_limit="97.5"/>
                    <measurement group_id="O4" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: I Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O2" value="85.7" lower_limit="42.1" upper_limit="96.6"/>
                    <measurement group_id="O3" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O4" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O6" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:28 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O2" value="71.4" lower_limit="29.0" upper_limit="96.3"/>
                    <measurement group_id="O3" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O4" value="75.0" lower_limit="34.9" upper_limit="96.8"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="30.8"/>
                    <measurement group_id="O8" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O9" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O10" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:152 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="9"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="8"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O4" value="50.0" lower_limit="15.7" upper_limit="84.3"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.9"/>
                    <measurement group_id="O6" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="66.7" lower_limit="29.9" upper_limit="92.5"/>
                    <measurement group_id="O9" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                    <measurement group_id="O10" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GII.4: II Run:365 Days PD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="7"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="10"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="9"/>
                    <count group_id="O10" value="7"/>
                    <count group_id="O11" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="4.3" upper_limit="77.7"/>
                    <measurement group_id="O2" value="57.1" lower_limit="18.4" upper_limit="90.1"/>
                    <measurement group_id="O3" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O4" value="42.9" lower_limit="9.9" upper_limit="81.6"/>
                    <measurement group_id="O5" value="14.3" lower_limit="0.4" upper_limit="57.6"/>
                    <measurement group_id="O6" value="62.5" lower_limit="24.5" upper_limit="91.5"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O9" value="22.2" lower_limit="2.8" upper_limit="60.0"/>
                    <measurement group_id="O10" value="100.0" lower_limit="59.0" upper_limit="100.0"/>
                    <measurement group_id="O11" value="0.0" lower_limit="0.0" upper_limit="41.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Treatment-emergent adverse events are adverse events that started after the first dose of study drug and up to 365 Days after post dose 2 (Day 393)</time_frame>
      <desc>At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Cohort A1: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 5/5 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (5 mcg of GI.1 norovirus VLP and 5 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E2">
          <title>Cohort A2: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 15/15 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (15 mcg of GI.1 norovirus VLP and 15 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E3">
          <title>Cohort A3: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E4">
          <title>Cohort A4:Norovirus Bivalent GI.1/GII.4 VLP Vaccine 150/150mcg</title>
          <description>Norovirus bivalent VLP Vaccine (150 mcg of GI.1 norovirus VLP and 150 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E5">
          <title>Cohort A1-A4: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E6">
          <title>Cohort B: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="E7">
          <title>Cohort B: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 50-64 years.</description>
        </group>
        <group group_id="E8">
          <title>Cohort C: Norovirus Bivalent GI.1/GII.4 VLP Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="E9">
          <title>Cohort C: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 65-85 years.</description>
        </group>
        <group group_id="E10">
          <title>Cohort D: Norovirus Bivalent VLP GI.1/GII.4 Vaccine 50/50 mcg</title>
          <description>Norovirus bivalent VLP Vaccine (50 mcg of GI.1 norovirus VLP and 50 mcg of GII.4 norovirus VLP) adjuvanted with 50 mcg MPL and 500 mcg Al(OH)3, injection, intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
        <group group_id="E11">
          <title>Cohort D: Placebo</title>
          <description>Norovirus Bivalent VLP Placebo-matching injection (0.9% NaCl and preservative-free), intramuscularly, on Days 0 and 28 in participants aged 18-49 years.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Idiopathic central retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastroparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fractured right fibula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding following urologic surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Motion sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Injection site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Croup infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nail bed infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Eosinophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lymphocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Mean cell haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neutrophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Red cell distribution width increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Capillary fragility</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>No publication related to study results will be made without Sponsorâs prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Takeda</name_or_title>
      <organization>Medical Director</organization>
      <phone>+1-877-825-3327</phone>
      <email>trialdisclosures@takeda.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

